CA2234609C - 2-amino-6-anilino-purine derivatives and processes for their preparation - Google Patents
2-amino-6-anilino-purine derivatives and processes for their preparation Download PDFInfo
- Publication number
- CA2234609C CA2234609C CA002234609A CA2234609A CA2234609C CA 2234609 C CA2234609 C CA 2234609C CA 002234609 A CA002234609 A CA 002234609A CA 2234609 A CA2234609 A CA 2234609A CA 2234609 C CA2234609 C CA 2234609C
- Authority
- CA
- Canada
- Prior art keywords
- amino
- ethyl
- phenyl
- purine
- chloro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- AWRCGEJILTVONY-UHFFFAOYSA-N 6-n-phenyl-7h-purine-2,6-diamine Chemical class C=12NC=NC2=NC(N)=NC=1NC1=CC=CC=C1 AWRCGEJILTVONY-UHFFFAOYSA-N 0.000 title claims abstract description 7
- 238000000034 method Methods 0.000 title claims description 32
- 230000008569 process Effects 0.000 title claims description 23
- 238000002360 preparation method Methods 0.000 title claims description 21
- -1 piperazin-1-yl-carbonyl Chemical group 0.000 claims abstract description 751
- 150000001875 compounds Chemical class 0.000 claims abstract description 119
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 99
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 96
- 150000003839 salts Chemical class 0.000 claims abstract description 67
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 65
- 125000003282 alkyl amino group Chemical group 0.000 claims abstract description 53
- 125000003545 alkoxy group Chemical group 0.000 claims abstract description 52
- 239000001257 hydrogen Substances 0.000 claims abstract description 47
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 47
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 45
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims abstract description 37
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims abstract description 34
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract description 32
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims abstract description 31
- 229910052736 halogen Inorganic materials 0.000 claims abstract description 30
- 125000005115 alkyl carbamoyl group Chemical group 0.000 claims abstract description 26
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims abstract description 22
- 229910052757 nitrogen Inorganic materials 0.000 claims abstract description 21
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims abstract description 17
- 229910052760 oxygen Inorganic materials 0.000 claims abstract description 17
- 239000001301 oxygen Substances 0.000 claims abstract description 17
- 229910052717 sulfur Inorganic materials 0.000 claims abstract description 17
- 125000002252 acyl group Chemical group 0.000 claims abstract description 15
- 206010028980 Neoplasm Diseases 0.000 claims abstract description 14
- 125000005236 alkanoylamino group Chemical group 0.000 claims abstract description 13
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims abstract description 13
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims abstract description 12
- 125000002947 alkylene group Chemical group 0.000 claims abstract description 12
- 125000005842 heteroatom Chemical group 0.000 claims abstract description 12
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 claims abstract description 12
- 239000011593 sulfur Substances 0.000 claims abstract description 12
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims abstract description 12
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 claims abstract description 11
- 125000004423 acyloxy group Chemical group 0.000 claims abstract description 7
- 150000003254 radicals Chemical class 0.000 claims description 53
- 125000001424 substituent group Chemical group 0.000 claims description 33
- 125000006239 protecting group Chemical group 0.000 claims description 32
- 150000002367 halogens Chemical group 0.000 claims description 29
- 125000000524 functional group Chemical group 0.000 claims description 26
- 125000003277 amino group Chemical group 0.000 claims description 21
- 239000000460 chlorine Substances 0.000 claims description 20
- 229910052801 chlorine Inorganic materials 0.000 claims description 19
- 125000001183 hydrocarbyl group Chemical group 0.000 claims description 16
- 241001465754 Metazoa Species 0.000 claims description 15
- 150000005840 aryl radicals Chemical class 0.000 claims description 15
- 239000008194 pharmaceutical composition Substances 0.000 claims description 15
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 13
- 150000001412 amines Chemical class 0.000 claims description 13
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 claims description 11
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 claims description 10
- 125000001841 imino group Chemical group [H]N=* 0.000 claims description 9
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 8
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 8
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 claims description 7
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 claims description 7
- 125000002941 2-furyl group Chemical group O1C([*])=C([H])C([H])=C1[H] 0.000 claims description 6
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 claims description 6
- 125000001951 carbamoylamino group Chemical group C(N)(=O)N* 0.000 claims description 6
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 6
- 150000002148 esters Chemical class 0.000 claims description 6
- 229910052740 iodine Inorganic materials 0.000 claims description 6
- 125000004043 oxo group Chemical group O=* 0.000 claims description 6
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 6
- 125000003396 thiol group Chemical class [H]S* 0.000 claims description 6
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims description 5
- 125000004414 alkyl thio group Chemical group 0.000 claims description 5
- 125000000383 tetramethylene group Chemical group [H]C([H])([*:1])C([H])([H])C([H])([H])C([H])([H])[*:2] 0.000 claims description 5
- JNPVNIHVQDAPGV-UHFFFAOYSA-N 2-[[9-ethyl-6-(4-fluoroanilino)purin-2-yl]amino]ethanol Chemical compound N1=C(NCCO)N=C2N(CC)C=NC2=C1NC1=CC=C(F)C=C1 JNPVNIHVQDAPGV-UHFFFAOYSA-N 0.000 claims description 4
- LJNGHQATEXHFTP-UHFFFAOYSA-N 3-[[9-ethyl-6-[3-(trifluoromethyl)anilino]purin-2-yl]amino]propan-1-ol Chemical compound N1=C(NCCCO)N=C2N(CC)C=NC2=C1NC1=CC=CC(C(F)(F)F)=C1 LJNGHQATEXHFTP-UHFFFAOYSA-N 0.000 claims description 4
- LLKNJDANISFMJC-UHFFFAOYSA-N benzyl n-[4-[[9-ethyl-2-(2-hydroxyethylamino)purin-6-yl]amino]phenyl]carbamate Chemical compound N1=C(NCCO)N=C2N(CC)C=NC2=C1NC(C=C1)=CC=C1NC(=O)OCC1=CC=CC=C1 LLKNJDANISFMJC-UHFFFAOYSA-N 0.000 claims description 4
- 125000003739 carbamimidoyl group Chemical group C(N)(=N)* 0.000 claims description 4
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims description 4
- 239000003937 drug carrier Substances 0.000 claims description 4
- CQYKZYZOSSGEEV-CYBMUJFWSA-N (2r)-1-[6-(3-chloroanilino)-9-ethylpurin-2-yl]pyrrolidine-2-carboxamide Chemical compound N1=C(N2[C@H](CCC2)C(N)=O)N=C2N(CC)C=NC2=C1NC1=CC=CC(Cl)=C1 CQYKZYZOSSGEEV-CYBMUJFWSA-N 0.000 claims description 3
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims description 3
- LBLYYCQCTBFVLH-UHFFFAOYSA-M 2-methylbenzenesulfonate Chemical group CC1=CC=CC=C1S([O-])(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-M 0.000 claims description 3
- DIEYJCDILBBDAH-UHFFFAOYSA-N 2-n-(2-aminoethyl)-9-ethyl-6-n-[3-(trifluoromethyl)phenyl]purine-2,6-diamine Chemical compound N1=C(NCCN)N=C2N(CC)C=NC2=C1NC1=CC=CC(C(F)(F)F)=C1 DIEYJCDILBBDAH-UHFFFAOYSA-N 0.000 claims description 3
- UTBSBSOBZHXMHI-HUUCEWRRSA-N 2-n-[(1r,2r)-2-aminocyclohexyl]-6-n-(3-chlorophenyl)-9-ethylpurine-2,6-diamine Chemical compound N1=C(N[C@H]2[C@@H](CCCC2)N)N=C2N(CC)C=NC2=C1NC1=CC=CC(Cl)=C1 UTBSBSOBZHXMHI-HUUCEWRRSA-N 0.000 claims description 3
- UTBSBSOBZHXMHI-LSDHHAIUSA-N 2-n-[(1r,2s)-2-aminocyclohexyl]-6-n-(3-chlorophenyl)-9-ethylpurine-2,6-diamine Chemical compound N1=C(N[C@H]2[C@H](CCCC2)N)N=C2N(CC)C=NC2=C1NC1=CC=CC(Cl)=C1 UTBSBSOBZHXMHI-LSDHHAIUSA-N 0.000 claims description 3
- ZJIUJMWBIVKNFS-UHFFFAOYSA-N 2-n-[2-(2-aminoethylamino)ethyl]-6-n-(3-chlorophenyl)-9-ethylpurine-2,6-diamine Chemical compound N1=C(NCCNCCN)N=C2N(CC)C=NC2=C1NC1=CC=CC(Cl)=C1 ZJIUJMWBIVKNFS-UHFFFAOYSA-N 0.000 claims description 3
- 125000005073 adamantyl group Chemical group C12(CC3CC(CC(C1)C3)C2)* 0.000 claims description 3
- 125000000033 alkoxyamino group Chemical group 0.000 claims description 3
- 125000004656 alkyl sulfonylamino group Chemical group 0.000 claims description 3
- VTBDWFOWRXMHTO-UHFFFAOYSA-N ethyl 3-[(2-chloro-7h-purin-6-yl)amino]-2-methylbenzoate Chemical compound CCOC(=O)C1=CC=CC(NC=2C=3NC=NC=3N=C(Cl)N=2)=C1C VTBDWFOWRXMHTO-UHFFFAOYSA-N 0.000 claims description 3
- PTSASSOBZROJTE-UHFFFAOYSA-N ethyl 3-[(2-chloro-9-ethylpurin-6-yl)amino]-2-methylbenzoate Chemical compound CCOC(=O)C1=CC=CC(NC=2C=3N=CN(CC)C=3N=C(Cl)N=2)=C1C PTSASSOBZROJTE-UHFFFAOYSA-N 0.000 claims description 3
- LCZSHGMYRQOQDU-SNVBAGLBSA-N (2r)-1-[[6-(3-chloroanilino)-9-ethylpurin-2-yl]amino]propan-2-ol Chemical compound N1=C(NC[C@@H](C)O)N=C2N(CC)C=NC2=C1NC1=CC=CC(Cl)=C1 LCZSHGMYRQOQDU-SNVBAGLBSA-N 0.000 claims description 2
- ZBNSIWHRSJGXPO-GFCCVEGCSA-N (2r)-2-[[6-(4-aminoanilino)-9-ethylpurin-2-yl]amino]butan-1-ol Chemical compound C=12N=CN(CC)C2=NC(N[C@@H](CO)CC)=NC=1NC1=CC=C(N)C=C1 ZBNSIWHRSJGXPO-GFCCVEGCSA-N 0.000 claims description 2
- HSUHYEDVZHVJCJ-GFCCVEGCSA-N (2r)-2-[[6-[3,5-bis(trifluoromethyl)anilino]-9-ethylpurin-2-yl]amino]butan-1-ol Chemical compound C=12N=CN(CC)C2=NC(N[C@@H](CO)CC)=NC=1NC1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1 HSUHYEDVZHVJCJ-GFCCVEGCSA-N 0.000 claims description 2
- LUOFSIVXWNTHHG-SNVBAGLBSA-N (2r)-2-[[6-[4-chloro-3-(trifluoromethyl)anilino]-9-ethylpurin-2-yl]amino]butan-1-ol Chemical compound C=12N=CN(CC)C2=NC(N[C@@H](CO)CC)=NC=1NC1=CC=C(Cl)C(C(F)(F)F)=C1 LUOFSIVXWNTHHG-SNVBAGLBSA-N 0.000 claims description 2
- AMYQMTWPMGMMTQ-GFCCVEGCSA-N (2r)-2-[[9-ethyl-6-(3-fluoroanilino)purin-2-yl]amino]butan-1-ol Chemical compound C=12N=CN(CC)C2=NC(N[C@@H](CO)CC)=NC=1NC1=CC=CC(F)=C1 AMYQMTWPMGMMTQ-GFCCVEGCSA-N 0.000 claims description 2
- GWFQWQACPHMODW-GFCCVEGCSA-N (2r)-2-[[9-ethyl-6-(4-fluoroanilino)purin-2-yl]amino]butan-1-ol Chemical compound C=12N=CN(CC)C2=NC(N[C@@H](CO)CC)=NC=1NC1=CC=C(F)C=C1 GWFQWQACPHMODW-GFCCVEGCSA-N 0.000 claims description 2
- YDYNWPUQOWJFTO-GFCCVEGCSA-N (2r)-2-[[9-ethyl-6-[3-(trifluoromethyl)anilino]purin-2-yl]amino]butan-1-ol Chemical compound C=12N=CN(CC)C2=NC(N[C@@H](CO)CC)=NC=1NC1=CC=CC(C(F)(F)F)=C1 YDYNWPUQOWJFTO-GFCCVEGCSA-N 0.000 claims description 2
- LFDBCEZGMORVGP-GFCCVEGCSA-N (2r)-2-[[9-ethyl-6-[4-(trifluoromethyl)anilino]purin-2-yl]amino]butan-1-ol Chemical compound C=12N=CN(CC)C2=NC(N[C@@H](CO)CC)=NC=1NC1=CC=C(C(F)(F)F)C=C1 LFDBCEZGMORVGP-GFCCVEGCSA-N 0.000 claims description 2
- LCZSHGMYRQOQDU-JTQLQIEISA-N (2s)-1-[[6-(3-chloroanilino)-9-ethylpurin-2-yl]amino]propan-2-ol Chemical compound N1=C(NC[C@H](C)O)N=C2N(CC)C=NC2=C1NC1=CC=CC(Cl)=C1 LCZSHGMYRQOQDU-JTQLQIEISA-N 0.000 claims description 2
- IEYKKOSGFKCDCK-UHFFFAOYSA-N 1-[[6-(3-chloroanilino)-9-ethylpurin-2-yl]-methylamino]cyclohexan-1-ol Chemical compound N1=C(N(C)C2(O)CCCCC2)N=C2N(CC)C=NC2=C1NC1=CC=CC(Cl)=C1 IEYKKOSGFKCDCK-UHFFFAOYSA-N 0.000 claims description 2
- VDCPEHPHPJICCB-CQSZACIVSA-N 2-[(2r)-2-(aminomethyl)pyrrolidin-1-yl]-n-(3-chlorophenyl)-9-ethylpurin-6-amine Chemical compound N1=C(N2[C@H](CCC2)CN)N=C2N(CC)C=NC2=C1NC1=CC=CC(Cl)=C1 VDCPEHPHPJICCB-CQSZACIVSA-N 0.000 claims description 2
- VDCPEHPHPJICCB-AWEZNQCLSA-N 2-[(2s)-2-(aminomethyl)pyrrolidin-1-yl]-n-(3-chlorophenyl)-9-ethylpurin-6-amine Chemical compound N1=C(N2[C@@H](CCC2)CN)N=C2N(CC)C=NC2=C1NC1=CC=CC(Cl)=C1 VDCPEHPHPJICCB-AWEZNQCLSA-N 0.000 claims description 2
- FZQOIYJBNKTLLI-UHFFFAOYSA-N 2-[2-[[6-(3-chloroanilino)-9-ethylpurin-2-yl]amino]ethyl]guanidine Chemical compound N1=C(NCCNC(N)=N)N=C2N(CC)C=NC2=C1NC1=CC=CC(Cl)=C1 FZQOIYJBNKTLLI-UHFFFAOYSA-N 0.000 claims description 2
- QGWQYKMWGDJLPU-UHFFFAOYSA-N 2-[4-(2-aminoethyl)piperazin-1-yl]-n-(3-chlorophenyl)-9-ethylpurin-6-amine Chemical compound N1=C(N2CCN(CCN)CC2)N=C2N(CC)C=NC2=C1NC1=CC=CC(Cl)=C1 QGWQYKMWGDJLPU-UHFFFAOYSA-N 0.000 claims description 2
- BJGHBTLRFUFYBS-UHFFFAOYSA-N 2-[4-(2-aminoethyl)piperidin-1-yl]-n-(3-chlorophenyl)-9-ethylpurin-6-amine Chemical compound N1=C(N2CCC(CCN)CC2)N=C2N(CC)C=NC2=C1NC1=CC=CC(Cl)=C1 BJGHBTLRFUFYBS-UHFFFAOYSA-N 0.000 claims description 2
- PSCCDYUWFQSBBR-UHFFFAOYSA-N 2-[[6-(3-fluoroanilino)-9-propan-2-ylpurin-2-yl]amino]ethanol Chemical compound N1=C(NCCO)N=C2N(C(C)C)C=NC2=C1NC1=CC=CC(F)=C1 PSCCDYUWFQSBBR-UHFFFAOYSA-N 0.000 claims description 2
- GQDAOWXYXYPSEB-UHFFFAOYSA-N 2-[[6-[3,5-bis(trifluoromethyl)anilino]-9-ethylpurin-2-yl]amino]ethanol Chemical compound N1=C(NCCO)N=C2N(CC)C=NC2=C1NC1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1 GQDAOWXYXYPSEB-UHFFFAOYSA-N 0.000 claims description 2
- AXPFCBGHNKFCGY-UHFFFAOYSA-N 2-[[6-[4-chloro-3-(trifluoromethyl)anilino]-9-ethylpurin-2-yl]amino]ethanol Chemical compound N1=C(NCCO)N=C2N(CC)C=NC2=C1NC1=CC=C(Cl)C(C(F)(F)F)=C1 AXPFCBGHNKFCGY-UHFFFAOYSA-N 0.000 claims description 2
- IRGRXPXBLYTVKS-UHFFFAOYSA-N 2-[[9-ethyl-2-(2-hydroxyethylamino)purin-6-yl]amino]ethanol Chemical compound N1=C(NCCO)N=C2N(CC)C=NC2=C1NCCO IRGRXPXBLYTVKS-UHFFFAOYSA-N 0.000 claims description 2
- RYMVLPRCPUDOKH-UHFFFAOYSA-N 2-[[9-ethyl-6-(3-fluoroanilino)purin-2-yl]amino]ethanol Chemical compound N1=C(NCCO)N=C2N(CC)C=NC2=C1NC1=CC=CC(F)=C1 RYMVLPRCPUDOKH-UHFFFAOYSA-N 0.000 claims description 2
- PLYHQMXPVPPNDY-UHFFFAOYSA-N 2-[[9-ethyl-6-[4-(trifluoromethyl)anilino]purin-2-yl]amino]ethanol Chemical compound N1=C(NCCO)N=C2N(CC)C=NC2=C1NC1=CC=C(C(F)(F)F)C=C1 PLYHQMXPVPPNDY-UHFFFAOYSA-N 0.000 claims description 2
- QYHLOXVYPZVXLV-UHFFFAOYSA-N 2-n-(1-adamantyl)-6-n-(3-chlorophenyl)-9-ethylpurine-2,6-diamine Chemical compound N1=C(NC23CC4CC(CC(C4)C2)C3)N=C2N(CC)C=NC2=C1NC1=CC=CC(Cl)=C1 QYHLOXVYPZVXLV-UHFFFAOYSA-N 0.000 claims description 2
- MANPEIPVNZSOJW-UHFFFAOYSA-N 2-n-(2-aminoethyl)-6-n-(3-chlorophenyl)-9-ethylpurine-2,6-diamine Chemical compound N1=C(NCCN)N=C2N(CC)C=NC2=C1NC1=CC=CC(Cl)=C1 MANPEIPVNZSOJW-UHFFFAOYSA-N 0.000 claims description 2
- VSEFWWDZTWPHSY-UHFFFAOYSA-N 2-n-(2-aminoethyl)-6-n-(3-chlorophenyl)-9-propan-2-ylpurine-2,6-diamine Chemical compound N1=C(NCCN)N=C2N(C(C)C)C=NC2=C1NC1=CC=CC(Cl)=C1 VSEFWWDZTWPHSY-UHFFFAOYSA-N 0.000 claims description 2
- GNJKZKUJSYNKJT-UHFFFAOYSA-N 2-n-(2-aminoethyl)-6-n-(3-fluorophenyl)-9-propan-2-ylpurine-2,6-diamine Chemical compound N1=C(NCCN)N=C2N(C(C)C)C=NC2=C1NC1=CC=CC(F)=C1 GNJKZKUJSYNKJT-UHFFFAOYSA-N 0.000 claims description 2
- CAHHCKPKIYTNPC-UHFFFAOYSA-N 2-n-(2-aminoethyl)-6-n-(3-methoxyphenyl)-9-propan-2-ylpurine-2,6-diamine Chemical compound COC1=CC=CC(NC=2C=3N=CN(C=3N=C(NCCN)N=2)C(C)C)=C1 CAHHCKPKIYTNPC-UHFFFAOYSA-N 0.000 claims description 2
- PWJIJHKNCPUMRZ-UHFFFAOYSA-N 2-n-(2-aminoethyl)-6-n-(4-aminophenyl)-9-ethylpurine-2,6-diamine Chemical compound N1=C(NCCN)N=C2N(CC)C=NC2=C1NC1=CC=C(N)C=C1 PWJIJHKNCPUMRZ-UHFFFAOYSA-N 0.000 claims description 2
- XEMOIXGIGBBIFS-UHFFFAOYSA-N 2-n-(2-aminoethyl)-6-n-(4-fluorophenyl)-9-propan-2-ylpurine-2,6-diamine;hydrochloride Chemical compound Cl.N1=C(NCCN)N=C2N(C(C)C)C=NC2=C1NC1=CC=C(F)C=C1 XEMOIXGIGBBIFS-UHFFFAOYSA-N 0.000 claims description 2
- JKZQHFFHKPVFPD-UHFFFAOYSA-N 2-n-(2-aminoethyl)-6-n-[3,5-bis(trifluoromethyl)phenyl]-9-ethylpurine-2,6-diamine Chemical compound N1=C(NCCN)N=C2N(CC)C=NC2=C1NC1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1 JKZQHFFHKPVFPD-UHFFFAOYSA-N 0.000 claims description 2
- YSTPGBRGMATTGI-UHFFFAOYSA-N 2-n-(2-aminoethyl)-6-n-[4-chloro-3-(trifluoromethyl)phenyl]-9-ethylpurine-2,6-diamine Chemical compound N1=C(NCCN)N=C2N(CC)C=NC2=C1NC1=CC=C(Cl)C(C(F)(F)F)=C1 YSTPGBRGMATTGI-UHFFFAOYSA-N 0.000 claims description 2
- WADPIXLSLDNKJV-UHFFFAOYSA-N 2-n-(2-aminoethyl)-9-ethyl-6-n-(3-fluorophenyl)purine-2,6-diamine Chemical compound N1=C(NCCN)N=C2N(CC)C=NC2=C1NC1=CC=CC(F)=C1 WADPIXLSLDNKJV-UHFFFAOYSA-N 0.000 claims description 2
- ILROIODVZDBFGX-UHFFFAOYSA-N 2-n-(2-aminoethyl)-9-ethyl-6-n-(3-fluorophenyl)purine-2,6-diamine;hydrochloride Chemical compound Cl.N1=C(NCCN)N=C2N(CC)C=NC2=C1NC1=CC=CC(F)=C1 ILROIODVZDBFGX-UHFFFAOYSA-N 0.000 claims description 2
- HGYWOTOKOXQKSV-UHFFFAOYSA-N 2-n-(2-aminoethyl)-9-ethyl-6-n-(3-methoxyphenyl)purine-2,6-diamine Chemical compound N1=C(NCCN)N=C2N(CC)C=NC2=C1NC1=CC=CC(OC)=C1 HGYWOTOKOXQKSV-UHFFFAOYSA-N 0.000 claims description 2
- UWAPZEZKRLPWNK-UHFFFAOYSA-N 2-n-(2-aminoethyl)-9-ethyl-6-n-(4-fluorophenyl)purine-2,6-diamine Chemical compound N1=C(NCCN)N=C2N(CC)C=NC2=C1NC1=CC=C(F)C=C1 UWAPZEZKRLPWNK-UHFFFAOYSA-N 0.000 claims description 2
- JVQVEZLPGPPPNL-UHFFFAOYSA-N 2-n-(2-aminoethyl)-9-ethyl-6-n-[4-(trifluoromethyl)phenyl]purine-2,6-diamine Chemical compound N1=C(NCCN)N=C2N(CC)C=NC2=C1NC1=CC=C(C(F)(F)F)C=C1 JVQVEZLPGPPPNL-UHFFFAOYSA-N 0.000 claims description 2
- YCAODQVRNHYHTP-UHFFFAOYSA-N 2-n-(2-aminophenyl)-6-n-(3-chlorophenyl)-9-ethylpurine-2,6-diamine Chemical compound N1=C(NC=2C(=CC=CC=2)N)N=C2N(CC)C=NC2=C1NC1=CC=CC(Cl)=C1 YCAODQVRNHYHTP-UHFFFAOYSA-N 0.000 claims description 2
- UROUSFPGLFJVLC-UHFFFAOYSA-N 2-n-(3-aminophenyl)-6-n-(3-chlorophenyl)-9-ethylpurine-2,6-diamine Chemical compound N1=C(NC=2C=C(N)C=CC=2)N=C2N(CC)C=NC2=C1NC1=CC=CC(Cl)=C1 UROUSFPGLFJVLC-UHFFFAOYSA-N 0.000 claims description 2
- IKKPOUJRFXLTCL-UHFFFAOYSA-N 2-n-(4-aminocyclohexyl)-6-n-(3-chlorophenyl)-9-ethylpurine-2,6-diamine Chemical compound N1=C(NC2CCC(N)CC2)N=C2N(CC)C=NC2=C1NC1=CC=CC(Cl)=C1 IKKPOUJRFXLTCL-UHFFFAOYSA-N 0.000 claims description 2
- HQGWYZFEVAXYBG-LSDHHAIUSA-N 2-n-[(1r,2s)-2-aminocyclohexyl]-6-n-(4-aminophenyl)-9-ethylpurine-2,6-diamine Chemical compound N1=C(N[C@H]2[C@H](CCCC2)N)N=C2N(CC)C=NC2=C1NC1=CC=C(N)C=C1 HQGWYZFEVAXYBG-LSDHHAIUSA-N 0.000 claims description 2
- ORFSYVATCOOKDZ-LSDHHAIUSA-N 2-n-[(1r,2s)-2-aminocyclohexyl]-6-n-[3,5-bis(trifluoromethyl)phenyl]-9-ethylpurine-2,6-diamine Chemical compound N1=C(N[C@H]2[C@H](CCCC2)N)N=C2N(CC)C=NC2=C1NC1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1 ORFSYVATCOOKDZ-LSDHHAIUSA-N 0.000 claims description 2
- OLMFEESMMVNCEL-LSDHHAIUSA-N 2-n-[(1r,2s)-2-aminocyclohexyl]-6-n-[4-chloro-3-(trifluoromethyl)phenyl]-9-ethylpurine-2,6-diamine Chemical compound N1=C(N[C@H]2[C@H](CCCC2)N)N=C2N(CC)C=NC2=C1NC1=CC=C(Cl)C(C(F)(F)F)=C1 OLMFEESMMVNCEL-LSDHHAIUSA-N 0.000 claims description 2
- ZRXDUWHFUJAOKS-LSDHHAIUSA-N 2-n-[(1r,2s)-2-aminocyclohexyl]-9-ethyl-6-n-(3-fluorophenyl)purine-2,6-diamine Chemical compound N1=C(N[C@H]2[C@H](CCCC2)N)N=C2N(CC)C=NC2=C1NC1=CC=CC(F)=C1 ZRXDUWHFUJAOKS-LSDHHAIUSA-N 0.000 claims description 2
- JPRFEHTWEJOGRM-JKSUJKDBSA-N 2-n-[(1r,2s)-2-aminocyclohexyl]-9-ethyl-6-n-(3-methoxyphenyl)purine-2,6-diamine Chemical compound N1=C(N[C@H]2[C@H](CCCC2)N)N=C2N(CC)C=NC2=C1NC1=CC=CC(OC)=C1 JPRFEHTWEJOGRM-JKSUJKDBSA-N 0.000 claims description 2
- DHXKXXSINUXJGW-LSDHHAIUSA-N 2-n-[(1r,2s)-2-aminocyclohexyl]-9-ethyl-6-n-(4-fluorophenyl)purine-2,6-diamine Chemical compound N1=C(N[C@H]2[C@H](CCCC2)N)N=C2N(CC)C=NC2=C1NC1=CC=C(F)C=C1 DHXKXXSINUXJGW-LSDHHAIUSA-N 0.000 claims description 2
- FXLBOAHJTHXVHX-LSDHHAIUSA-N 2-n-[(1r,2s)-2-aminocyclohexyl]-9-ethyl-6-n-[4-(trifluoromethyl)phenyl]purine-2,6-diamine Chemical compound N1=C(N[C@H]2[C@H](CCCC2)N)N=C2N(CC)C=NC2=C1NC1=CC=C(C(F)(F)F)C=C1 FXLBOAHJTHXVHX-LSDHHAIUSA-N 0.000 claims description 2
- BGDKKXMMSUIPFS-GFCCVEGCSA-N 2-n-[(2r)-1-aminobutan-2-yl]-6-n-(3-chlorophenyl)-9-ethylpurine-2,6-diamine Chemical compound C=12N=CN(CC)C2=NC(N[C@@H](CN)CC)=NC=1NC1=CC=CC(Cl)=C1 BGDKKXMMSUIPFS-GFCCVEGCSA-N 0.000 claims description 2
- POPOWOGWYKGXQA-UHFFFAOYSA-N 3-[[2-(2-aminoethylamino)-9-ethylpurin-6-yl]amino]benzonitrile Chemical compound N1=C(NCCN)N=C2N(CC)C=NC2=C1NC1=CC=CC(C#N)=C1 POPOWOGWYKGXQA-UHFFFAOYSA-N 0.000 claims description 2
- AMZPODGJHRHDDA-UHFFFAOYSA-N 3-[[2-(2-aminoethylamino)-9-ethylpurin-6-yl]amino]benzonitrile;hydrochloride Chemical compound Cl.N1=C(NCCN)N=C2N(CC)C=NC2=C1NC1=CC=CC(C#N)=C1 AMZPODGJHRHDDA-UHFFFAOYSA-N 0.000 claims description 2
- XDKDDXAUYJNEMS-JKSUJKDBSA-N 3-[[2-[[(1r,2s)-2-aminocyclohexyl]amino]-9-ethylpurin-6-yl]amino]benzonitrile Chemical compound N1=C(N[C@H]2[C@H](CCCC2)N)N=C2N(CC)C=NC2=C1NC1=CC=CC(C#N)=C1 XDKDDXAUYJNEMS-JKSUJKDBSA-N 0.000 claims description 2
- IGSPIQFGZIPBHD-UHFFFAOYSA-N 3-[[6-(3-methoxyanilino)-9-propan-2-ylpurin-2-yl]amino]propan-1-ol Chemical compound COC1=CC=CC(NC=2C=3N=CN(C=3N=C(NCCCO)N=2)C(C)C)=C1 IGSPIQFGZIPBHD-UHFFFAOYSA-N 0.000 claims description 2
- DTIDNFGZODHYNM-UHFFFAOYSA-N 3-[[9-(2-hydroxyethyl)-6-(3-methoxyanilino)purin-2-yl]amino]propan-1-ol Chemical compound COC1=CC=CC(NC=2C=3N=CN(CCO)C=3N=C(NCCCO)N=2)=C1 DTIDNFGZODHYNM-UHFFFAOYSA-N 0.000 claims description 2
- WZTNLIGZCRYPTN-UHFFFAOYSA-N 3-[[9-ethyl-2-(3-hydroxypropylamino)purin-6-yl]amino]-n-(3-hydroxypropyl)-2-methylbenzamide Chemical compound N1=C(NCCCO)N=C2N(CC)C=NC2=C1NC1=CC=CC(C(=O)NCCCO)=C1C WZTNLIGZCRYPTN-UHFFFAOYSA-N 0.000 claims description 2
- MWEXNJNLIGBDAZ-CYBMUJFWSA-N 3-[[9-ethyl-2-[[(2r)-1-hydroxybutan-2-yl]amino]purin-6-yl]amino]benzonitrile Chemical compound C=12N=CN(CC)C2=NC(N[C@@H](CO)CC)=NC=1NC1=CC=CC(C#N)=C1 MWEXNJNLIGBDAZ-CYBMUJFWSA-N 0.000 claims description 2
- OOGPGJQOQBFQKP-UHFFFAOYSA-N 3-[[9-methyl-6-(3,4,5-trimethoxyanilino)purin-2-yl]amino]propan-1-ol Chemical compound COC1=C(OC)C(OC)=CC(NC=2C=3N=CN(C)C=3N=C(NCCCO)N=2)=C1 OOGPGJQOQBFQKP-UHFFFAOYSA-N 0.000 claims description 2
- CAXLURXTABGCKY-UHFFFAOYSA-N 3-chloro-n-[4-[[9-ethyl-2-(2-hydroxyethylamino)purin-6-yl]amino]phenyl]benzamide Chemical compound N1=C(NCCO)N=C2N(CC)C=NC2=C1NC(C=C1)=CC=C1NC(=O)C1=CC=CC(Cl)=C1 CAXLURXTABGCKY-UHFFFAOYSA-N 0.000 claims description 2
- LZLLZHRDZGWEJY-UHFFFAOYSA-N 6-n-(3-chlorophenyl)-2-n-cyclohexyl-9-ethylpurine-2,6-diamine Chemical compound N1=C(NC2CCCCC2)N=C2N(CC)C=NC2=C1NC1=CC=CC(Cl)=C1 LZLLZHRDZGWEJY-UHFFFAOYSA-N 0.000 claims description 2
- GARAVCGEQWHTHC-UHFFFAOYSA-N 6-n-(3-chlorophenyl)-9-ethyl-2-n-(4-methylcyclohexyl)purine-2,6-diamine Chemical compound N1=C(NC2CCC(C)CC2)N=C2N(CC)C=NC2=C1NC1=CC=CC(Cl)=C1 GARAVCGEQWHTHC-UHFFFAOYSA-N 0.000 claims description 2
- HBRHJDDJDROWKZ-UHFFFAOYSA-N 6-n-(3-chlorophenyl)-9-ethyl-2-n-[2-(1h-indol-3-yl)ethyl]purine-2,6-diamine Chemical compound N1=C(NCCC=2C3=CC=CC=C3NC=2)N=C2N(CC)C=NC2=C1NC1=CC=CC(Cl)=C1 HBRHJDDJDROWKZ-UHFFFAOYSA-N 0.000 claims description 2
- MMOAZILBIGYDFJ-UHFFFAOYSA-N 6-n-(3-chlorophenyl)-9-ethyl-2-n-[2-(methylamino)ethyl]purine-2,6-diamine Chemical compound N1=C(NCCNC)N=C2N(CC)C=NC2=C1NC1=CC=CC(Cl)=C1 MMOAZILBIGYDFJ-UHFFFAOYSA-N 0.000 claims description 2
- JDOQNYARSWZKMX-UHFFFAOYSA-N 9-ethyl-2-n-[2-(1h-imidazol-5-yl)ethyl]-6-n-(3-methoxyphenyl)purine-2,6-diamine Chemical compound N1=C(NCCC=2N=CNC=2)N=C2N(CC)C=NC2=C1NC1=CC=CC(OC)=C1 JDOQNYARSWZKMX-UHFFFAOYSA-N 0.000 claims description 2
- NZCACIXSTDRVPY-OTVXOJSOSA-N CCn1cnc2c(Nc3ccc(cc3)C(F)(F)F)nc(N[C@@H]3CC[C@H](N)CC3)nc12 Chemical compound CCn1cnc2c(Nc3ccc(cc3)C(F)(F)F)nc(N[C@@H]3CC[C@H](N)CC3)nc12 NZCACIXSTDRVPY-OTVXOJSOSA-N 0.000 claims description 2
- QFBYWLHDWLVZMJ-OTVXOJSOSA-N N1=C(N[C@H]2CC[C@@H](N)CC2)N=C2N(CC)C=NC2=C1NC1=CC=C(N)C=C1 Chemical compound N1=C(N[C@H]2CC[C@@H](N)CC2)N=C2N(CC)C=NC2=C1NC1=CC=C(N)C=C1 QFBYWLHDWLVZMJ-OTVXOJSOSA-N 0.000 claims description 2
- CXHGPPMJWUFXCK-OKILXGFUSA-N N[C@H]1CC[C@H](CC1)NC1=NC(=C2N=CN(C2=N1)CC)NC1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F Chemical compound N[C@H]1CC[C@H](CC1)NC1=NC(=C2N=CN(C2=N1)CC)NC1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F CXHGPPMJWUFXCK-OKILXGFUSA-N 0.000 claims description 2
- 125000004450 alkenylene group Chemical group 0.000 claims description 2
- 125000004457 alkyl amino carbonyl group Chemical group 0.000 claims description 2
- 125000004670 alkyl amino thio carbonyl group Chemical group 0.000 claims description 2
- 125000000043 benzamido group Chemical group [H]N([*])C(=O)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 claims description 2
- BSXHXBRBSQUJGH-OKILXGFUSA-N chembl172811 Chemical compound N1=C(N[C@H]2CC[C@@H](N)CC2)N=C2N(CC)C=NC2=C1NC1=CC=CC(OC)=C1 BSXHXBRBSQUJGH-OKILXGFUSA-N 0.000 claims description 2
- WKESGRBZSRGRRG-OKILXGFUSA-N chembl173353 Chemical compound N1=C(N[C@H]2CC[C@@H](N)CC2)N=C2N(CC)C=NC2=C1NC1=CC=CC(F)=C1 WKESGRBZSRGRRG-OKILXGFUSA-N 0.000 claims description 2
- GPINDKALSCBEKJ-OTVXOJSOSA-N chembl173619 Chemical compound N1=C(N[C@H]2CC[C@@H](N)CC2)N=C2N(CC)C=NC2=C1NC1=CC=C(F)C=C1 GPINDKALSCBEKJ-OTVXOJSOSA-N 0.000 claims description 2
- ITNUIFJLBYTNFE-OKILXGFUSA-N chembl174162 Chemical compound N1=C(N[C@H]2CC[C@@H](N)CC2)N=C2N(CC)C=NC2=C1NC1=CC=CC(C(F)(F)F)=C1 ITNUIFJLBYTNFE-OKILXGFUSA-N 0.000 claims description 2
- DYAAPRUNBKMNMF-GASCZTMLSA-N chembl176908 Chemical compound N1=C(N[C@H]2CC[C@@H](N)CC2)N=C2N(CC)C=NC2=C1NC1=CC=CC(C#N)=C1 DYAAPRUNBKMNMF-GASCZTMLSA-N 0.000 claims description 2
- QYBNTDWVGSUIRZ-CTYIDZIISA-N chembl368215 Chemical compound N1=C(N[C@@H]2CC[C@@H](O)CC2)N=C2N(CC)C=NC2=C1NC1=CC=CC(C(F)(F)F)=C1 QYBNTDWVGSUIRZ-CTYIDZIISA-N 0.000 claims description 2
- RPHGNWRLKOTWLP-UHFFFAOYSA-N n-(3-chlorophenyl)-9-ethyl-2-piperazin-1-ylpurin-6-amine Chemical compound N1=C(N2CCNCC2)N=C2N(CC)C=NC2=C1NC1=CC=CC(Cl)=C1 RPHGNWRLKOTWLP-UHFFFAOYSA-N 0.000 claims description 2
- 238000002512 chemotherapy Methods 0.000 claims 4
- 125000005002 aryl methyl group Chemical group 0.000 claims 2
- UUHWYUVOPCYSOQ-GFCCVEGCSA-N (2r)-2-[[9-ethyl-6-(3-methoxyanilino)purin-2-yl]amino]butan-1-ol Chemical compound C=12N=CN(CC)C2=NC(N[C@@H](CO)CC)=NC=1NC1=CC=CC(OC)=C1 UUHWYUVOPCYSOQ-GFCCVEGCSA-N 0.000 claims 1
- CWEOUSKTQYEABI-LSDHHAIUSA-N 2-[(1s,2r)-2-[[6-(3-chloroanilino)-9-ethylpurin-2-yl]amino]cyclohexyl]guanidine Chemical compound N1=C(N[C@H]2[C@H](CCCC2)NC(N)=N)N=C2N(CC)C=NC2=C1NC1=CC=CC(Cl)=C1 CWEOUSKTQYEABI-LSDHHAIUSA-N 0.000 claims 1
- WZUZEBQIFLVJBI-UHFFFAOYSA-N 2-[6-(3-chloroanilino)-9-ethylpurin-2-yl]guanidine Chemical compound N1=C(NC(N)=N)N=C2N(CC)C=NC2=C1NC1=CC=CC(Cl)=C1 WZUZEBQIFLVJBI-UHFFFAOYSA-N 0.000 claims 1
- GYNMRWQEUDQNIQ-UHFFFAOYSA-N 2-[[6-(3-chloroanilino)-9-ethylpurin-2-yl]amino]propane-1,3-diol Chemical compound N1=C(NC(CO)CO)N=C2N(CC)C=NC2=C1NC1=CC=CC(Cl)=C1 GYNMRWQEUDQNIQ-UHFFFAOYSA-N 0.000 claims 1
- MLCGJAAZOYNXIK-UHFFFAOYSA-N 2-n-(2-aminoethyl)-9-ethyl-6-n-(4-fluorophenyl)purine-2,6-diamine;hydrochloride Chemical compound Cl.N1=C(NCCN)N=C2N(CC)C=NC2=C1NC1=CC=C(F)C=C1 MLCGJAAZOYNXIK-UHFFFAOYSA-N 0.000 claims 1
- OMLBDSQGJYDWMS-LSDHHAIUSA-N 2-n-[(1r,2s)-2-aminocyclohexyl]-9-ethyl-6-n-[3-(trifluoromethyl)phenyl]purine-2,6-diamine Chemical compound N1=C(N[C@H]2[C@H](CCCC2)N)N=C2N(CC)C=NC2=C1NC1=CC=CC(C(F)(F)F)=C1 OMLBDSQGJYDWMS-LSDHHAIUSA-N 0.000 claims 1
- JXZIZOIXGMUPSK-ZFWWWQNUSA-N 2-n-[(1s,3s)-3-aminocyclohexyl]-6-n-(3-chlorophenyl)-9-ethylpurine-2,6-diamine Chemical compound N1=C(N[C@@H]2C[C@@H](N)CCC2)N=C2N(CC)C=NC2=C1NC1=CC=CC(Cl)=C1 JXZIZOIXGMUPSK-ZFWWWQNUSA-N 0.000 claims 1
- YXNUJHDJBJRCEF-UHFFFAOYSA-N 2-n-[3-(aminomethyl)phenyl]-6-n-(3-chlorophenyl)-9-ethyl-2-n-methylpurine-2,6-diamine Chemical compound N1=C(N(C)C=2C=C(CN)C=CC=2)N=C2N(CC)C=NC2=C1NC1=CC=CC(Cl)=C1 YXNUJHDJBJRCEF-UHFFFAOYSA-N 0.000 claims 1
- GJNBMDWPSFMMSN-UHFFFAOYSA-N 3-[[9-ethyl-6-(3-methoxyanilino)purin-2-yl]amino]propan-1-ol Chemical compound N1=C(NCCCO)N=C2N(CC)C=NC2=C1NC1=CC=CC(OC)=C1 GJNBMDWPSFMMSN-UHFFFAOYSA-N 0.000 claims 1
- MVUGGALLMXEHCN-CTYIDZIISA-N C(C)N1C2=NC(=NC(=C2N=C1)NC1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)N[C@@H]1CC[C@H](CC1)O Chemical compound C(C)N1C2=NC(=NC(=C2N=C1)NC1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)N[C@@H]1CC[C@H](CC1)O MVUGGALLMXEHCN-CTYIDZIISA-N 0.000 claims 1
- CXHGPPMJWUFXCK-HDJSIYSDSA-N CCn1cnc2c(Nc3cc(cc(c3)C(F)(F)F)C(F)(F)F)nc(N[C@H]3CC[C@H](N)CC3)nc12 Chemical compound CCn1cnc2c(Nc3cc(cc(c3)C(F)(F)F)C(F)(F)F)nc(N[C@H]3CC[C@H](N)CC3)nc12 CXHGPPMJWUFXCK-HDJSIYSDSA-N 0.000 claims 1
- NZCACIXSTDRVPY-CTYIDZIISA-N N1=C(N[C@@H]2CC[C@@H](N)CC2)N=C2N(CC)C=NC2=C1NC1=CC=C(C(F)(F)F)C=C1 Chemical compound N1=C(N[C@@H]2CC[C@@H](N)CC2)N=C2N(CC)C=NC2=C1NC1=CC=C(C(F)(F)F)C=C1 NZCACIXSTDRVPY-CTYIDZIISA-N 0.000 claims 1
- WQDLHQOUGVRWFA-HAQNSBGRSA-N N1=C(N[C@@H]2CC[C@@H](N)CC2)N=C2N(CC)C=NC2=C1NC1=CC=C(Cl)C(C(F)(F)F)=C1 Chemical compound N1=C(N[C@@H]2CC[C@@H](N)CC2)N=C2N(CC)C=NC2=C1NC1=CC=C(Cl)C(C(F)(F)F)=C1 WQDLHQOUGVRWFA-HAQNSBGRSA-N 0.000 claims 1
- QFBYWLHDWLVZMJ-CTYIDZIISA-N N1=C(N[C@@H]2CC[C@@H](N)CC2)N=C2N(CC)C=NC2=C1NC1=CC=C(N)C=C1 Chemical compound N1=C(N[C@@H]2CC[C@@H](N)CC2)N=C2N(CC)C=NC2=C1NC1=CC=C(N)C=C1 QFBYWLHDWLVZMJ-CTYIDZIISA-N 0.000 claims 1
- YGTLMLHSFAEQSO-SHTZXODSSA-N N1=C(N[C@@H]2CC[C@@H](O)CC2)N=C2N(CC)C=NC2=C1NC1=CC=C(C(F)(F)F)C=C1 Chemical compound N1=C(N[C@@H]2CC[C@@H](O)CC2)N=C2N(CC)C=NC2=C1NC1=CC=C(C(F)(F)F)C=C1 YGTLMLHSFAEQSO-SHTZXODSSA-N 0.000 claims 1
- SUCUYPLKEOKPNF-AULYBMBSSA-N N1=C(N[C@@H]2CC[C@@H](O)CC2)N=C2N(CC)C=NC2=C1NC1=CC=C(Cl)C(C(F)(F)F)=C1 Chemical compound N1=C(N[C@@H]2CC[C@@H](O)CC2)N=C2N(CC)C=NC2=C1NC1=CC=C(Cl)C(C(F)(F)F)=C1 SUCUYPLKEOKPNF-AULYBMBSSA-N 0.000 claims 1
- OOVJMJNORLFMSN-SHTZXODSSA-N N1=C(N[C@@H]2CC[C@@H](O)CC2)N=C2N(CC)C=NC2=C1NC1=CC=C(N)C=C1 Chemical compound N1=C(N[C@@H]2CC[C@@H](O)CC2)N=C2N(CC)C=NC2=C1NC1=CC=C(N)C=C1 OOVJMJNORLFMSN-SHTZXODSSA-N 0.000 claims 1
- WQDLHQOUGVRWFA-TXEJJXNPSA-N N1=C(N[C@H]2CC[C@@H](N)CC2)N=C2N(CC)C=NC2=C1NC1=CC=C(Cl)C(C(F)(F)F)=C1 Chemical compound N1=C(N[C@H]2CC[C@@H](N)CC2)N=C2N(CC)C=NC2=C1NC1=CC=C(Cl)C(C(F)(F)F)=C1 WQDLHQOUGVRWFA-TXEJJXNPSA-N 0.000 claims 1
- DTQVDTLACAAQTR-UHFFFAOYSA-M Trifluoroacetate Chemical compound [O-]C(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-M 0.000 claims 1
- INOQUZXUCBEROH-AWEZNQCLSA-N [(2s)-1-[6-(3-chloroanilino)-9-ethylpurin-2-yl]pyrrolidin-2-yl]methanol Chemical compound N1=C(N2[C@@H](CCC2)CO)N=C2N(CC)C=NC2=C1NC1=CC=CC(Cl)=C1 INOQUZXUCBEROH-AWEZNQCLSA-N 0.000 claims 1
- CHIPNLIUTFFIAI-UHFFFAOYSA-N [1-[6-(3-chloroanilino)-9-ethylpurin-2-yl]piperidin-2-yl]methanol Chemical compound N1=C(N2C(CCCC2)CO)N=C2N(CC)C=NC2=C1NC1=CC=CC(Cl)=C1 CHIPNLIUTFFIAI-UHFFFAOYSA-N 0.000 claims 1
- GPINDKALSCBEKJ-CTYIDZIISA-N chembl171891 Chemical compound N1=C(N[C@@H]2CC[C@@H](N)CC2)N=C2N(CC)C=NC2=C1NC1=CC=C(F)C=C1 GPINDKALSCBEKJ-CTYIDZIISA-N 0.000 claims 1
- YREVWYJUWQLUFX-KOMQPUFPSA-N chembl172140 Chemical compound N1=C(N[C@@H]2CC[C@@H](O)CC2)N=C2N(CC)C=NC2=C1NC1=CC=CC(C#N)=C1 YREVWYJUWQLUFX-KOMQPUFPSA-N 0.000 claims 1
- ITNUIFJLBYTNFE-HDJSIYSDSA-N chembl173608 Chemical compound N1=C(N[C@@H]2CC[C@@H](N)CC2)N=C2N(CC)C=NC2=C1NC1=CC=CC(C(F)(F)F)=C1 ITNUIFJLBYTNFE-HDJSIYSDSA-N 0.000 claims 1
- CYMWNIIJIXYBNA-CTYIDZIISA-N chembl174773 Chemical compound N1=C(N[C@@H]2CC[C@@H](O)CC2)N=C2N(CC)C=NC2=C1NC1=CC=CC(F)=C1 CYMWNIIJIXYBNA-CTYIDZIISA-N 0.000 claims 1
- VRGIDUUVTFCUIU-SHTZXODSSA-N chembl174977 Chemical compound N1=C(N[C@@H]2CC[C@@H](O)CC2)N=C2N(CC)C=NC2=C1NC1=CC=C(F)C=C1 VRGIDUUVTFCUIU-SHTZXODSSA-N 0.000 claims 1
- BSXHXBRBSQUJGH-HDJSIYSDSA-N chembl176834 Chemical compound N1=C(N[C@@H]2CC[C@@H](N)CC2)N=C2N(CC)C=NC2=C1NC1=CC=CC(OC)=C1 BSXHXBRBSQUJGH-HDJSIYSDSA-N 0.000 claims 1
- WKESGRBZSRGRRG-HDJSIYSDSA-N chembl366642 Chemical compound N1=C(N[C@@H]2CC[C@@H](N)CC2)N=C2N(CC)C=NC2=C1NC1=CC=CC(F)=C1 WKESGRBZSRGRRG-HDJSIYSDSA-N 0.000 claims 1
- WIQAYDNWTUCRTM-CTYIDZIISA-N chembl368202 Chemical compound N1=C(N[C@@H]2CC[C@@H](O)CC2)N=C2N(CC)C=NC2=C1NC1=CC=CC(OC)=C1 WIQAYDNWTUCRTM-CTYIDZIISA-N 0.000 claims 1
- DYAAPRUNBKMNMF-SHTZXODSSA-N chembl435330 Chemical compound N1=C(N[C@@H]2CC[C@@H](N)CC2)N=C2N(CC)C=NC2=C1NC1=CC=CC(C#N)=C1 DYAAPRUNBKMNMF-SHTZXODSSA-N 0.000 claims 1
- 125000002962 imidazol-1-yl group Chemical group [*]N1C([H])=NC([H])=C1[H] 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 10
- 108091000080 Phosphotransferase Proteins 0.000 abstract description 8
- 201000010099 disease Diseases 0.000 abstract description 8
- 102000020233 phosphotransferase Human genes 0.000 abstract description 8
- 125000005843 halogen group Chemical group 0.000 abstract description 5
- 102000016736 Cyclin Human genes 0.000 abstract description 2
- 108050006400 Cyclin Proteins 0.000 abstract description 2
- 230000003463 hyperproliferative effect Effects 0.000 abstract description 2
- 102000009728 CDC2 Protein Kinase Human genes 0.000 abstract 1
- 108010034798 CDC2 Protein Kinase Proteins 0.000 abstract 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 219
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 202
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 135
- 238000004992 fast atom bombardment mass spectroscopy Methods 0.000 description 134
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 84
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 84
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 75
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 68
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 67
- 229940093499 ethyl acetate Drugs 0.000 description 67
- 235000019439 ethyl acetate Nutrition 0.000 description 67
- WDQNKEAFSDIEMK-UHFFFAOYSA-N 2-chloro-n-(3-chlorophenyl)-9-ethylpurin-6-amine Chemical compound N1=C(Cl)N=C2N(CC)C=NC2=C1NC1=CC=CC(Cl)=C1 WDQNKEAFSDIEMK-UHFFFAOYSA-N 0.000 description 64
- 239000000203 mixture Substances 0.000 description 64
- 238000004128 high performance liquid chromatography Methods 0.000 description 63
- 238000000746 purification Methods 0.000 description 54
- 239000000243 solution Substances 0.000 description 51
- 235000002639 sodium chloride Nutrition 0.000 description 46
- 229940073584 methylene chloride Drugs 0.000 description 45
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 40
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 36
- 230000029087 digestion Effects 0.000 description 34
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 32
- 238000004440 column chromatography Methods 0.000 description 31
- 239000007858 starting material Substances 0.000 description 31
- 239000002904 solvent Substances 0.000 description 30
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 27
- 239000012071 phase Substances 0.000 description 27
- 239000011541 reaction mixture Substances 0.000 description 27
- GQHTUMJGOHRCHB-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine Chemical compound C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 description 26
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 26
- 239000000741 silica gel Substances 0.000 description 26
- 229910002027 silica gel Inorganic materials 0.000 description 26
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 25
- 229910052938 sodium sulfate Inorganic materials 0.000 description 25
- 235000011152 sodium sulphate Nutrition 0.000 description 25
- 239000004480 active ingredient Substances 0.000 description 23
- 238000006243 chemical reaction Methods 0.000 description 23
- 239000013078 crystal Substances 0.000 description 23
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 22
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 21
- 239000011521 glass Substances 0.000 description 21
- 239000002253 acid Substances 0.000 description 20
- 229910000024 caesium carbonate Inorganic materials 0.000 description 20
- 239000012074 organic phase Substances 0.000 description 19
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 18
- 239000000126 substance Substances 0.000 description 18
- RMFWVOLULURGJI-UHFFFAOYSA-N 2,6-dichloro-7h-purine Chemical compound ClC1=NC(Cl)=C2NC=NC2=N1 RMFWVOLULURGJI-UHFFFAOYSA-N 0.000 description 17
- 239000002244 precipitate Substances 0.000 description 17
- 229930195733 hydrocarbon Natural products 0.000 description 15
- 239000003921 oil Substances 0.000 description 15
- 235000019198 oils Nutrition 0.000 description 15
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 14
- 239000000194 fatty acid Substances 0.000 description 14
- HVTICUPFWKNHNG-UHFFFAOYSA-N iodoethane Chemical compound CCI HVTICUPFWKNHNG-UHFFFAOYSA-N 0.000 description 14
- 230000002829 reductive effect Effects 0.000 description 14
- 239000000725 suspension Substances 0.000 description 14
- 238000003820 Medium-pressure liquid chromatography Methods 0.000 description 13
- 238000007792 addition Methods 0.000 description 13
- 229910052799 carbon Inorganic materials 0.000 description 13
- 235000014113 dietary fatty acids Nutrition 0.000 description 13
- 229930195729 fatty acid Natural products 0.000 description 13
- 238000001914 filtration Methods 0.000 description 13
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 12
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 12
- 210000004027 cell Anatomy 0.000 description 12
- 238000004587 chromatography analysis Methods 0.000 description 12
- 238000001816 cooling Methods 0.000 description 12
- 239000012043 crude product Substances 0.000 description 12
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 11
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 11
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 11
- 125000003342 alkenyl group Chemical group 0.000 description 11
- 235000011114 ammonium hydroxide Nutrition 0.000 description 11
- 239000000706 filtrate Substances 0.000 description 11
- 229920001223 polyethylene glycol Chemical class 0.000 description 11
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 10
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 10
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 10
- 239000000908 ammonium hydroxide Substances 0.000 description 10
- 125000002837 carbocyclic group Chemical group 0.000 description 10
- 239000004215 Carbon black (E152) Substances 0.000 description 9
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 125000002015 acyclic group Chemical group 0.000 description 9
- 239000002585 base Substances 0.000 description 9
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 9
- 229920006395 saturated elastomer Polymers 0.000 description 9
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 8
- 125000003118 aryl group Chemical group 0.000 description 8
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 8
- 239000012267 brine Substances 0.000 description 8
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 8
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 7
- 239000002202 Polyethylene glycol Chemical class 0.000 description 7
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 7
- 229910052794 bromium Inorganic materials 0.000 description 7
- 125000004093 cyano group Chemical group *C#N 0.000 description 7
- 238000001035 drying Methods 0.000 description 7
- 239000000284 extract Substances 0.000 description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical group C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 6
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 6
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 6
- 125000004466 alkoxycarbonylamino group Chemical group 0.000 description 6
- 239000008346 aqueous phase Substances 0.000 description 6
- 238000002425 crystallisation Methods 0.000 description 6
- 230000008025 crystallization Effects 0.000 description 6
- 239000003995 emulsifying agent Substances 0.000 description 6
- 239000011737 fluorine Substances 0.000 description 6
- 229910052731 fluorine Inorganic materials 0.000 description 6
- 125000000623 heterocyclic group Chemical group 0.000 description 6
- 150000002430 hydrocarbons Chemical class 0.000 description 6
- FMKOJHQHASLBPH-UHFFFAOYSA-N isopropyl iodide Chemical compound CC(C)I FMKOJHQHASLBPH-UHFFFAOYSA-N 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 6
- 239000002674 ointment Substances 0.000 description 6
- 239000000546 pharmaceutical excipient Substances 0.000 description 6
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 6
- 241000208199 Buxus sempervirens Species 0.000 description 5
- 102000002427 Cyclin B Human genes 0.000 description 5
- 108010068150 Cyclin B Proteins 0.000 description 5
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 5
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 5
- WUGQZFFCHPXWKQ-UHFFFAOYSA-N Propanolamine Chemical compound NCCCO WUGQZFFCHPXWKQ-UHFFFAOYSA-N 0.000 description 5
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 5
- 150000007513 acids Chemical class 0.000 description 5
- 238000006136 alcoholysis reaction Methods 0.000 description 5
- 229940024606 amino acid Drugs 0.000 description 5
- 229910052786 argon Inorganic materials 0.000 description 5
- 239000002775 capsule Substances 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 238000000576 coating method Methods 0.000 description 5
- 239000006071 cream Substances 0.000 description 5
- 239000007903 gelatin capsule Substances 0.000 description 5
- 125000002795 guanidino group Chemical group C(N)(=N)N* 0.000 description 5
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 5
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 5
- 235000019341 magnesium sulphate Nutrition 0.000 description 5
- 125000002950 monocyclic group Chemical group 0.000 description 5
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 5
- 238000006722 reduction reaction Methods 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 238000003797 solvolysis reaction Methods 0.000 description 5
- 239000000600 sorbitol Substances 0.000 description 5
- 125000004434 sulfur atom Chemical group 0.000 description 5
- 239000000454 talc Substances 0.000 description 5
- 229910052623 talc Inorganic materials 0.000 description 5
- 235000012222 talc Nutrition 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- VEMDTFVUDJLJKF-UHFFFAOYSA-N 2-chloro-n-(3-methoxyphenyl)-7h-purin-6-amine Chemical compound COC1=CC=CC(NC=2C=3NC=NC=3N=C(Cl)N=2)=C1 VEMDTFVUDJLJKF-UHFFFAOYSA-N 0.000 description 4
- OUGMTFOKIWDDOO-UHFFFAOYSA-N 2-chloro-n-[3-(trifluoromethyl)phenyl]-7h-purin-6-amine Chemical compound FC(F)(F)C1=CC=CC(NC=2C=3NC=NC=3N=C(Cl)N=2)=C1 OUGMTFOKIWDDOO-UHFFFAOYSA-N 0.000 description 4
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 4
- SQFVYHPSQNPXSL-UHFFFAOYSA-N 3-[[6-(3-methoxyanilino)-7h-purin-2-yl]amino]propan-1-ol Chemical compound COC1=CC=CC(NC=2C=3NC=NC=3N=C(NCCCO)N=2)=C1 SQFVYHPSQNPXSL-UHFFFAOYSA-N 0.000 description 4
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 239000005711 Benzoic acid Substances 0.000 description 4
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 4
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 4
- 239000005662 Paraffin oil Substances 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- 229920002472 Starch Polymers 0.000 description 4
- 125000004442 acylamino group Chemical group 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- 125000001931 aliphatic group Chemical group 0.000 description 4
- 229910052783 alkali metal Inorganic materials 0.000 description 4
- 235000010233 benzoic acid Nutrition 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 239000001768 carboxy methyl cellulose Substances 0.000 description 4
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 4
- 239000003054 catalyst Substances 0.000 description 4
- 125000000392 cycloalkenyl group Chemical group 0.000 description 4
- GUVUOGQBMYCBQP-UHFFFAOYSA-N dmpu Chemical compound CN1CCCN(C)C1=O GUVUOGQBMYCBQP-UHFFFAOYSA-N 0.000 description 4
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 4
- 150000002191 fatty alcohols Chemical class 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N formic acid Substances OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 4
- 125000005456 glyceride group Chemical group 0.000 description 4
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 4
- 125000002883 imidazolyl group Chemical group 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- 239000000543 intermediate Substances 0.000 description 4
- 239000011630 iodine Substances 0.000 description 4
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 4
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 4
- 125000001624 naphthyl group Chemical group 0.000 description 4
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 4
- WQEPLUUGTLDZJY-UHFFFAOYSA-N pentadecanoic acid Chemical compound CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 4
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 4
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 4
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- 125000004076 pyridyl group Chemical group 0.000 description 4
- 125000002294 quinazolinyl group Chemical group N1=C(N=CC2=CC=CC=C12)* 0.000 description 4
- 125000005493 quinolyl group Chemical group 0.000 description 4
- 238000001953 recrystallisation Methods 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 235000017557 sodium bicarbonate Nutrition 0.000 description 4
- 239000003381 stabilizer Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 150000005846 sugar alcohols Polymers 0.000 description 4
- 125000000020 sulfo group Chemical group O=S(=O)([*])O[H] 0.000 description 4
- BUUAVVFTZIICAW-UHFFFAOYSA-N 2-[[6-(4-aminoanilino)-9-ethylpurin-2-yl]amino]ethanol Chemical compound N1=C(NCCO)N=C2N(CC)C=NC2=C1NC1=CC=C(N)C=C1 BUUAVVFTZIICAW-UHFFFAOYSA-N 0.000 description 3
- RCMICPXXYUMLCM-UHFFFAOYSA-N 2-chloro-9-ethyl-n-(3-fluorophenyl)purin-6-amine Chemical compound N1=C(Cl)N=C2N(CC)C=NC2=C1NC1=CC=CC(F)=C1 RCMICPXXYUMLCM-UHFFFAOYSA-N 0.000 description 3
- INXGQHMTSJBNMG-UHFFFAOYSA-N 2-chloro-9-ethyl-n-(4-fluorophenyl)purin-6-amine Chemical compound N1=C(Cl)N=C2N(CC)C=NC2=C1NC1=CC=C(F)C=C1 INXGQHMTSJBNMG-UHFFFAOYSA-N 0.000 description 3
- NQRNWNORZMRCRR-UHFFFAOYSA-N 2-chloro-9-ethyl-n-[3-(trifluoromethyl)phenyl]purin-6-amine Chemical compound N1=C(Cl)N=C2N(CC)C=NC2=C1NC1=CC=CC(C(F)(F)F)=C1 NQRNWNORZMRCRR-UHFFFAOYSA-N 0.000 description 3
- PGPQRKGCHHVFPY-UHFFFAOYSA-N 2-chloro-n-(3-chlorophenyl)-7h-purin-6-amine Chemical compound ClC1=CC=CC(NC=2C=3NC=NC=3N=C(Cl)N=2)=C1 PGPQRKGCHHVFPY-UHFFFAOYSA-N 0.000 description 3
- GCANLUVJHHUMQW-UHFFFAOYSA-N 2-chloro-n-(3-fluorophenyl)-7h-purin-6-amine Chemical compound FC1=CC=CC(NC=2C=3NC=NC=3N=C(Cl)N=2)=C1 GCANLUVJHHUMQW-UHFFFAOYSA-N 0.000 description 3
- BUSWQNPLWYLUSJ-UHFFFAOYSA-N 2-chloro-n-(3-methoxyphenyl)-9-propan-2-ylpurin-6-amine Chemical compound COC1=CC=CC(NC=2C=3N=CN(C=3N=C(Cl)N=2)C(C)C)=C1 BUSWQNPLWYLUSJ-UHFFFAOYSA-N 0.000 description 3
- YSOJRPRNKAJZBA-UHFFFAOYSA-N 2-chloro-n-(4-fluorophenyl)-7h-purin-6-amine Chemical compound C1=CC(F)=CC=C1NC1=NC(Cl)=NC2=C1NC=N2 YSOJRPRNKAJZBA-UHFFFAOYSA-N 0.000 description 3
- NLDAKQGAEBXLIU-UHFFFAOYSA-N 2-chloro-n-(4-fluorophenyl)-9-propan-2-ylpurin-6-amine Chemical compound N1=C(Cl)N=C2N(C(C)C)C=NC2=C1NC1=CC=C(F)C=C1 NLDAKQGAEBXLIU-UHFFFAOYSA-N 0.000 description 3
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 230000010337 G2 phase Effects 0.000 description 3
- 108010010803 Gelatin Proteins 0.000 description 3
- 239000004166 Lanolin Substances 0.000 description 3
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 3
- 102000001253 Protein Kinase Human genes 0.000 description 3
- 230000018199 S phase Effects 0.000 description 3
- 235000021355 Stearic acid Nutrition 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 3
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 3
- 150000001335 aliphatic alkanes Chemical class 0.000 description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 3
- 238000000668 atmospheric pressure chemical ionisation mass spectrometry Methods 0.000 description 3
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 3
- 229960000541 cetyl alcohol Drugs 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000000470 constituent Substances 0.000 description 3
- 125000000753 cycloalkyl group Chemical group 0.000 description 3
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 3
- 239000006185 dispersion Substances 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 238000011049 filling Methods 0.000 description 3
- 239000008273 gelatin Substances 0.000 description 3
- 229920000159 gelatin Polymers 0.000 description 3
- 235000019322 gelatine Nutrition 0.000 description 3
- 235000011852 gelatine desserts Nutrition 0.000 description 3
- 150000002334 glycols Chemical class 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 235000019359 magnesium stearate Nutrition 0.000 description 3
- 238000004949 mass spectrometry Methods 0.000 description 3
- 150000007522 mineralic acids Chemical class 0.000 description 3
- 125000004433 nitrogen atom Chemical group N* 0.000 description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 3
- 150000007524 organic acids Chemical class 0.000 description 3
- 125000004430 oxygen atom Chemical group O* 0.000 description 3
- 238000007911 parenteral administration Methods 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 229910000027 potassium carbonate Inorganic materials 0.000 description 3
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 3
- 108060006633 protein kinase Proteins 0.000 description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 3
- 125000000467 secondary amino group Chemical group [H]N([*:1])[*:2] 0.000 description 3
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 3
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 3
- 239000007901 soft capsule Substances 0.000 description 3
- 239000008117 stearic acid Substances 0.000 description 3
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 3
- 125000001302 tertiary amino group Chemical group 0.000 description 3
- 125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 3
- 229940099259 vaseline Drugs 0.000 description 3
- 229920002554 vinyl polymer Polymers 0.000 description 3
- SSJXIUAHEKJCMH-WDSKDSINSA-N (1s,2s)-cyclohexane-1,2-diamine Chemical compound N[C@H]1CCCC[C@@H]1N SSJXIUAHEKJCMH-WDSKDSINSA-N 0.000 description 2
- CQYKZYZOSSGEEV-ZDUSSCGKSA-N (2s)-1-[6-(3-chloroanilino)-9-ethylpurin-2-yl]pyrrolidine-2-carboxamide Chemical compound N1=C(N2[C@@H](CCC2)C(N)=O)N=C2N(CC)C=NC2=C1NC1=CC=CC(Cl)=C1 CQYKZYZOSSGEEV-ZDUSSCGKSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 description 2
- RXYPXQSKLGGKOL-UHFFFAOYSA-N 1,4-dimethylpiperazine Chemical compound CN1CCN(C)CC1 RXYPXQSKLGGKOL-UHFFFAOYSA-N 0.000 description 2
- CBCKQZAAMUWICA-UHFFFAOYSA-N 1,4-phenylenediamine Chemical compound NC1=CC=C(N)C=C1 CBCKQZAAMUWICA-UHFFFAOYSA-N 0.000 description 2
- HPZMWTNATZPBIH-UHFFFAOYSA-N 1-methyladenine Chemical compound CN1C=NC2=NC=NC2=C1N HPZMWTNATZPBIH-UHFFFAOYSA-N 0.000 description 2
- 125000001637 1-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C(*)=C([H])C([H])=C([H])C2=C1[H] 0.000 description 2
- OXRKNOIREWJPSD-UHFFFAOYSA-N 2,6-dichloro-7-ethylpurine Chemical compound ClC1=NC(Cl)=C2N(CC)C=NC2=N1 OXRKNOIREWJPSD-UHFFFAOYSA-N 0.000 description 2
- PRESUDAFHFFHLT-UHFFFAOYSA-N 2,6-dichloro-9-ethylpurine Chemical compound N1=C(Cl)N=C2N(CC)C=NC2=C1Cl PRESUDAFHFFHLT-UHFFFAOYSA-N 0.000 description 2
- OIQOAYVCKAHSEJ-UHFFFAOYSA-N 2-[2,3-bis(2-hydroxyethoxy)propoxy]ethanol;hexadecanoic acid;octadecanoic acid Chemical compound OCCOCC(OCCO)COCCO.CCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O OIQOAYVCKAHSEJ-UHFFFAOYSA-N 0.000 description 2
- 125000004174 2-benzimidazolyl group Chemical group [H]N1C(*)=NC2=C([H])C([H])=C([H])C([H])=C12 0.000 description 2
- XHPODVFWROPTGN-UHFFFAOYSA-N 2-chloro-9-ethyl-n-(3-methoxyphenyl)purin-6-amine Chemical compound N1=C(Cl)N=C2N(CC)C=NC2=C1NC1=CC=CC(OC)=C1 XHPODVFWROPTGN-UHFFFAOYSA-N 0.000 description 2
- GMHJEOHWQGPBKO-UHFFFAOYSA-N 2-chloro-9-methyl-n-(3,4,5-trimethoxyphenyl)purin-6-amine Chemical compound COC1=C(OC)C(OC)=CC(NC=2C=3N=CN(C)C=3N=C(Cl)N=2)=C1 GMHJEOHWQGPBKO-UHFFFAOYSA-N 0.000 description 2
- BRSRQYFONOLISO-UHFFFAOYSA-N 2-chloro-n-(3,4,5-trimethoxyphenyl)-7h-purin-6-amine Chemical compound COC1=C(OC)C(OC)=CC(NC=2C=3NC=NC=3N=C(Cl)N=2)=C1 BRSRQYFONOLISO-UHFFFAOYSA-N 0.000 description 2
- ZHIMHIHAHRYXJY-UHFFFAOYSA-N 2-chloro-n-(3-chlorophenyl)-9-propan-2-ylpurin-6-amine Chemical compound N1=C(Cl)N=C2N(C(C)C)C=NC2=C1NC1=CC=CC(Cl)=C1 ZHIMHIHAHRYXJY-UHFFFAOYSA-N 0.000 description 2
- WHBWKJUBIPUNIA-UHFFFAOYSA-N 2-chloro-n-(3-fluorophenyl)-9-propan-2-ylpurin-6-amine Chemical compound N1=C(Cl)N=C2N(C(C)C)C=NC2=C1NC1=CC=CC(F)=C1 WHBWKJUBIPUNIA-UHFFFAOYSA-N 0.000 description 2
- KURMFCMCKUEFNJ-UHFFFAOYSA-N 2-chloro-n-(4-chlorophenyl)-7-ethylpurin-6-amine Chemical compound C=12N(CC)C=NC2=NC(Cl)=NC=1NC1=CC=C(Cl)C=C1 KURMFCMCKUEFNJ-UHFFFAOYSA-N 0.000 description 2
- GKLZOVLEOIOMSU-UHFFFAOYSA-N 2-chloro-n-(4-nitrophenyl)-9-propan-2-ylpurin-6-amine Chemical compound N1=C(Cl)N=C2N(C(C)C)C=NC2=C1NC1=CC=C([N+]([O-])=O)C=C1 GKLZOVLEOIOMSU-UHFFFAOYSA-N 0.000 description 2
- JQIBUUUUKCRWHD-UHFFFAOYSA-N 2-chloro-n-[4-chloro-3-(trifluoromethyl)phenyl]-7h-purin-6-amine Chemical compound C1=C(Cl)C(C(F)(F)F)=CC(NC=2C=3NC=NC=3N=C(Cl)N=2)=C1 JQIBUUUUKCRWHD-UHFFFAOYSA-N 0.000 description 2
- ZZFHUVIVYNLMSW-UHFFFAOYSA-N 2-chloro-n-[4-chloro-3-(trifluoromethyl)phenyl]-9-ethylpurin-6-amine Chemical compound N1=C(Cl)N=C2N(CC)C=NC2=C1NC1=CC=C(Cl)C(C(F)(F)F)=C1 ZZFHUVIVYNLMSW-UHFFFAOYSA-N 0.000 description 2
- 125000001731 2-cyanoethyl group Chemical group [H]C([H])(*)C([H])([H])C#N 0.000 description 2
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 2
- 125000001622 2-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C(*)C([H])=C([H])C2=C1[H] 0.000 description 2
- 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 description 2
- SJSOFNCYXJUNBT-UHFFFAOYSA-N 3,4,5-trimethoxybenzoic acid Chemical compound COC1=CC(C(O)=O)=CC(OC)=C1OC SJSOFNCYXJUNBT-UHFFFAOYSA-N 0.000 description 2
- VIUDTWATMPPKEL-UHFFFAOYSA-N 3-(trifluoromethyl)aniline Chemical compound NC1=CC=CC(C(F)(F)F)=C1 VIUDTWATMPPKEL-UHFFFAOYSA-N 0.000 description 2
- FIYWQMQQPXWGTJ-UHFFFAOYSA-N 3-[(2-chloro-9-ethylpurin-6-yl)amino]benzonitrile Chemical compound N1=C(Cl)N=C2N(CC)C=NC2=C1NC1=CC=CC(C#N)=C1 FIYWQMQQPXWGTJ-UHFFFAOYSA-N 0.000 description 2
- LULAYUGMBFYYEX-UHFFFAOYSA-N 3-chlorobenzoic acid Chemical compound OC(=O)C1=CC=CC(Cl)=C1 LULAYUGMBFYYEX-UHFFFAOYSA-N 0.000 description 2
- 125000006201 3-phenylpropyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 description 2
- 125000001541 3-thienyl group Chemical group S1C([H])=C([*])C([H])=C1[H] 0.000 description 2
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 2
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical class OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- 229920002307 Dextran Polymers 0.000 description 2
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 229930195725 Mannitol Natural products 0.000 description 2
- LGDSHSYDSCRFAB-UHFFFAOYSA-N Methyl isothiocyanate Chemical compound CN=C=S LGDSHSYDSCRFAB-UHFFFAOYSA-N 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 2
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
- OKJIRPAQVSHGFK-UHFFFAOYSA-N N-acetylglycine Chemical compound CC(=O)NCC(O)=O OKJIRPAQVSHGFK-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- 235000021314 Palmitic acid Nutrition 0.000 description 2
- 235000019483 Peanut oil Nutrition 0.000 description 2
- BHHGXPLMPWCGHP-UHFFFAOYSA-N Phenethylamine Chemical compound NCCC1=CC=CC=C1 BHHGXPLMPWCGHP-UHFFFAOYSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- 229920002565 Polyethylene Glycol 400 Polymers 0.000 description 2
- 201000004681 Psoriasis Diseases 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical group [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 description 2
- 150000001241 acetals Chemical class 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 150000001340 alkali metals Chemical class 0.000 description 2
- 125000000266 alpha-aminoacyl group Chemical group 0.000 description 2
- DKNWSYNQZKUICI-UHFFFAOYSA-N amantadine Chemical compound C1C(C2)CC3CC2CC1(N)C3 DKNWSYNQZKUICI-UHFFFAOYSA-N 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 150000003863 ammonium salts Chemical class 0.000 description 2
- 125000005428 anthryl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C3C(*)=C([H])C([H])=C([H])C3=C([H])C2=C1[H] 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 235000003704 aspartic acid Nutrition 0.000 description 2
- 125000000852 azido group Chemical group *N=[N+]=[N-] 0.000 description 2
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 description 2
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 2
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 description 2
- 125000004541 benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 description 2
- PITLFTKLRFOUEJ-UHFFFAOYSA-N benzyl n-(4-aminophenyl)carbamate Chemical compound C1=CC(N)=CC=C1NC(=O)OCC1=CC=CC=C1 PITLFTKLRFOUEJ-UHFFFAOYSA-N 0.000 description 2
- JFDQUSZDNRUJBU-UHFFFAOYSA-N benzyl n-[4-[(2-chloro-7h-purin-6-yl)amino]phenyl]carbamate Chemical compound C=12NC=NC2=NC(Cl)=NC=1NC(C=C1)=CC=C1NC(=O)OCC1=CC=CC=C1 JFDQUSZDNRUJBU-UHFFFAOYSA-N 0.000 description 2
- IZGXFEYWNRVBKB-UHFFFAOYSA-N benzyl n-[4-[(2-chloro-9-ethylpurin-6-yl)amino]phenyl]carbamate Chemical compound N1=C(Cl)N=C2N(CC)C=NC2=C1NC(C=C1)=CC=C1NC(=O)OCC1=CC=CC=C1 IZGXFEYWNRVBKB-UHFFFAOYSA-N 0.000 description 2
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 2
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- AIYUHDOJVYHVIT-UHFFFAOYSA-M caesium chloride Chemical compound [Cl-].[Cs+] AIYUHDOJVYHVIT-UHFFFAOYSA-M 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 230000032823 cell division Effects 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 239000003638 chemical reducing agent Substances 0.000 description 2
- 125000004230 chromenyl group Chemical group O1C(C=CC2=CC=CC=C12)* 0.000 description 2
- 125000000490 cinnamyl group Chemical group C(C=CC1=CC=CC=C1)* 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 150000004292 cyclic ethers Chemical class 0.000 description 2
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 2
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 2
- KQWGXHWJMSMDJJ-UHFFFAOYSA-N cyclohexyl isocyanate Chemical compound O=C=NC1CCCCC1 KQWGXHWJMSMDJJ-UHFFFAOYSA-N 0.000 description 2
- PAFZNILMFXTMIY-UHFFFAOYSA-N cyclohexylamine Chemical compound NC1CCCCC1 PAFZNILMFXTMIY-UHFFFAOYSA-N 0.000 description 2
- 125000000640 cyclooctyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 2
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 2
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 2
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical group C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 2
- 125000005982 diphenylmethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- ZQPPMHVWECSIRJ-MDZDMXLPSA-N elaidic acid Chemical compound CCCCCCCC\C=C\CCCCCCCC(O)=O ZQPPMHVWECSIRJ-MDZDMXLPSA-N 0.000 description 2
- 238000002451 electron ionisation mass spectrometry Methods 0.000 description 2
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 125000002541 furyl group Chemical group 0.000 description 2
- 210000004051 gastric juice Anatomy 0.000 description 2
- 229940052308 general anesthetics halogenated hydrocarbons Drugs 0.000 description 2
- 235000013922 glutamic acid Nutrition 0.000 description 2
- 239000004220 glutamic acid Substances 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 150000008282 halocarbons Chemical class 0.000 description 2
- 239000007902 hard capsule Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- KEMQGTRYUADPNZ-UHFFFAOYSA-N heptadecanoic acid Chemical compound CCCCCCCCCCCCCCCCC(O)=O KEMQGTRYUADPNZ-UHFFFAOYSA-N 0.000 description 2
- 239000003906 humectant Substances 0.000 description 2
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine hydrate Chemical compound O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 2
- 238000007327 hydrogenolysis reaction Methods 0.000 description 2
- 125000004464 hydroxyphenyl group Chemical group 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 125000001041 indolyl group Chemical group 0.000 description 2
- 239000012442 inert solvent Substances 0.000 description 2
- 230000016507 interphase Effects 0.000 description 2
- 238000007912 intraperitoneal administration Methods 0.000 description 2
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 2
- TWBYWOBDOCUKOW-UHFFFAOYSA-N isonicotinic acid Chemical compound OC(=O)C1=CC=NC=C1 TWBYWOBDOCUKOW-UHFFFAOYSA-N 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- 125000005956 isoquinolyl group Chemical group 0.000 description 2
- 125000000468 ketone group Chemical group 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 235000019388 lanolin Nutrition 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- 125000000040 m-tolyl group Chemical group [H]C1=C([H])C(*)=C([H])C(=C1[H])C([H])([H])[H] 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 2
- 230000011278 mitosis Effects 0.000 description 2
- 125000004312 morpholin-2-yl group Chemical group [H]N1C([H])([H])C([H])([H])OC([H])(*)C1([H])[H] 0.000 description 2
- 125000004572 morpholin-3-yl group Chemical group N1C(COCC1)* 0.000 description 2
- HNHVTXYLRVGMHD-UHFFFAOYSA-N n-butyl isocyanate Chemical compound CCCCN=C=O HNHVTXYLRVGMHD-UHFFFAOYSA-N 0.000 description 2
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 2
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- XTEGVFVZDVNBPF-UHFFFAOYSA-N naphthalene-1,5-disulfonic acid Chemical compound C1=CC=C2C(S(=O)(=O)O)=CC=CC2=C1S(O)(=O)=O XTEGVFVZDVNBPF-UHFFFAOYSA-N 0.000 description 2
- BDJRBEYXGGNYIS-UHFFFAOYSA-N nonanedioic acid Chemical compound OC(=O)CCCCCCCC(O)=O BDJRBEYXGGNYIS-UHFFFAOYSA-N 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 125000003261 o-tolyl group Chemical group [H]C1=C([H])C(*)=C(C([H])=C1[H])C([H])([H])[H] 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 210000000287 oocyte Anatomy 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 125000002971 oxazolyl group Chemical group 0.000 description 2
- 125000001037 p-tolyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 description 2
- 239000012188 paraffin wax Substances 0.000 description 2
- 239000000312 peanut oil Substances 0.000 description 2
- 125000003356 phenylsulfanyl group Chemical group [*]SC1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 2
- WLJVNTCWHIRURA-UHFFFAOYSA-N pimelic acid Chemical compound OC(=O)CCCCCC(O)=O WLJVNTCWHIRURA-UHFFFAOYSA-N 0.000 description 2
- 125000003367 polycyclic group Chemical group 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 125000000246 pyrimidin-2-yl group Chemical group [H]C1=NC(*)=NC([H])=C1[H] 0.000 description 2
- 125000004527 pyrimidin-4-yl group Chemical group N1=CN=C(C=C1)* 0.000 description 2
- 125000000714 pyrimidinyl group Chemical group 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 2
- 125000003808 silyl group Chemical group [H][Si]([H])([H])[*] 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- TYFQFVWCELRYAO-UHFFFAOYSA-N suberic acid Chemical compound OC(=O)CCCCCCC(O)=O TYFQFVWCELRYAO-UHFFFAOYSA-N 0.000 description 2
- 125000000547 substituted alkyl group Chemical group 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 239000000829 suppository Substances 0.000 description 2
- 239000002511 suppository base Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- DLYUQMMRRRQYAE-UHFFFAOYSA-N tetraphosphorus decaoxide Chemical compound O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 2
- 125000001544 thienyl group Chemical group 0.000 description 2
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical class [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
- SZHOJFHSIKHZHA-UHFFFAOYSA-N tridecanoic acid Chemical compound CCCCCCCCCCCCC(O)=O SZHOJFHSIKHZHA-UHFFFAOYSA-N 0.000 description 2
- QAEDZJGFFMLHHQ-UHFFFAOYSA-N trifluoroacetic anhydride Chemical compound FC(F)(F)C(=O)OC(=O)C(F)(F)F QAEDZJGFFMLHHQ-UHFFFAOYSA-N 0.000 description 2
- XFNJVJPLKCPIBV-UHFFFAOYSA-N trimethylenediamine Chemical compound NCCCN XFNJVJPLKCPIBV-UHFFFAOYSA-N 0.000 description 2
- APJYDQYYACXCRM-UHFFFAOYSA-N tryptamine Chemical compound C1=CC=C2C(CCN)=CNC2=C1 APJYDQYYACXCRM-UHFFFAOYSA-N 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 229940100445 wheat starch Drugs 0.000 description 2
- 239000008096 xylene Substances 0.000 description 2
- PDNZJLMPXLQDPL-UHFFFAOYSA-N (1-aminocyclopentyl)methanol Chemical compound OCC1(N)CCCC1 PDNZJLMPXLQDPL-UHFFFAOYSA-N 0.000 description 1
- LKKCSUHCVGCGFA-KGZKBUQUSA-N (1r,2r)-2-aminocyclohexan-1-ol;hydrochloride Chemical compound Cl.N[C@@H]1CCCC[C@H]1O LKKCSUHCVGCGFA-KGZKBUQUSA-N 0.000 description 1
- SSJXIUAHEKJCMH-PHDIDXHHSA-N (1r,2r)-cyclohexane-1,2-diamine Chemical compound N[C@@H]1CCCC[C@H]1N SSJXIUAHEKJCMH-PHDIDXHHSA-N 0.000 description 1
- AQBBTFGZSATNML-CABCVRRESA-N (1s,2r)-2-[[6-(3-chloroanilino)-9-ethylpurin-2-yl]amino]cyclohexan-1-ol Chemical compound N1=C(N[C@H]2[C@H](CCCC2)O)N=C2N(CC)C=NC2=C1NC1=CC=CC(Cl)=C1 AQBBTFGZSATNML-CABCVRRESA-N 0.000 description 1
- SSJXIUAHEKJCMH-OLQVQODUSA-N (1s,2r)-cyclohexane-1,2-diamine Chemical compound N[C@H]1CCCC[C@H]1N SSJXIUAHEKJCMH-OLQVQODUSA-N 0.000 description 1
- HXKKHQJGJAFBHI-GSVOUGTGSA-N (2R)-1-aminopropan-2-ol Chemical compound C[C@@H](O)CN HXKKHQJGJAFBHI-GSVOUGTGSA-N 0.000 description 1
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- JCBPETKZIGVZRE-SCSAIBSYSA-N (2r)-2-aminobutan-1-ol Chemical compound CC[C@@H](N)CO JCBPETKZIGVZRE-SCSAIBSYSA-N 0.000 description 1
- VLJNHYLEOZPXFW-SCSAIBSYSA-N (2r)-pyrrolidine-2-carboxamide Chemical compound NC(=O)[C@H]1CCCN1 VLJNHYLEOZPXFW-SCSAIBSYSA-N 0.000 description 1
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- KWMLJOLKUYYJFJ-DIHCEYMBSA-N (2r,3s,4r,5r)-2,3,4,5,6,7-hexahydroxyheptanoic acid Chemical compound OCC(O)[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O KWMLJOLKUYYJFJ-DIHCEYMBSA-N 0.000 description 1
- HXKKHQJGJAFBHI-VKHMYHEASA-N (2s)-1-aminopropan-2-ol Chemical compound C[C@H](O)CN HXKKHQJGJAFBHI-VKHMYHEASA-N 0.000 description 1
- LNBOBOGLIWLIHC-LBPRGKRZSA-N (2s)-2-[[6-(3-chloroanilino)-9-ethylpurin-2-yl]amino]butan-1-ol Chemical compound C=12N=CN(CC)C2=NC(N[C@H](CO)CC)=NC=1NC1=CC=CC(Cl)=C1 LNBOBOGLIWLIHC-LBPRGKRZSA-N 0.000 description 1
- JCBPETKZIGVZRE-BYPYZUCNSA-N (2s)-2-aminobutan-1-ol Chemical compound CC[C@H](N)CO JCBPETKZIGVZRE-BYPYZUCNSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- AFENDNXGAFYKQO-VKHMYHEASA-N (S)-2-hydroxybutyric acid Chemical compound CC[C@H](O)C(O)=O AFENDNXGAFYKQO-VKHMYHEASA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- UWYVPFMHMJIBHE-OWOJBTEDSA-N (e)-2-hydroxybut-2-enedioic acid Chemical compound OC(=O)\C=C(\O)C(O)=O UWYVPFMHMJIBHE-OWOJBTEDSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- OPCJOXGBLDJWRM-UHFFFAOYSA-N 1,2-diamino-2-methylpropane Chemical compound CC(C)(N)CN OPCJOXGBLDJWRM-UHFFFAOYSA-N 0.000 description 1
- DDMOUSALMHHKOS-UHFFFAOYSA-N 1,2-dichloro-1,1,2,2-tetrafluoroethane Chemical compound FC(F)(Cl)C(F)(F)Cl DDMOUSALMHHKOS-UHFFFAOYSA-N 0.000 description 1
- UYBWIEGTWASWSR-UHFFFAOYSA-N 1,3-diaminopropan-2-ol Chemical compound NCC(O)CN UYBWIEGTWASWSR-UHFFFAOYSA-N 0.000 description 1
- WZCQRUWWHSTZEM-UHFFFAOYSA-N 1,3-phenylenediamine Chemical compound NC1=CC=CC(N)=C1 WZCQRUWWHSTZEM-UHFFFAOYSA-N 0.000 description 1
- KPKNTUUIEVXMOH-UHFFFAOYSA-N 1,4-dioxa-8-azaspiro[4.5]decane Chemical compound O1CCOC11CCNCC1 KPKNTUUIEVXMOH-UHFFFAOYSA-N 0.000 description 1
- ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 description 1
- YVRNMFZVSVUMKX-UHFFFAOYSA-N 1-[6-(3-chloroanilino)-9-ethylpurin-2-yl]-1-methylurea Chemical compound N1=C(N(C)C(N)=O)N=C2N(CC)C=NC2=C1NC1=CC=CC(Cl)=C1 YVRNMFZVSVUMKX-UHFFFAOYSA-N 0.000 description 1
- VMKUXXUHAANDAK-UHFFFAOYSA-N 1-[6-(3-chloroanilino)-9-ethylpurin-2-yl]-2-methylpiperidin-2-ol Chemical compound N1=C(N2C(CCCC2)(C)O)N=C2N(CC)C=NC2=C1NC1=CC=CC(Cl)=C1 VMKUXXUHAANDAK-UHFFFAOYSA-N 0.000 description 1
- IJTGTRYFJGUTBE-UHFFFAOYSA-N 1-[6-(3-chloroanilino)-9-ethylpurin-2-yl]piperidin-4-ol Chemical compound N1=C(N2CCC(O)CC2)N=C2N(CC)C=NC2=C1NC1=CC=CC(Cl)=C1 IJTGTRYFJGUTBE-UHFFFAOYSA-N 0.000 description 1
- GXIHFMPIJZXDMF-UHFFFAOYSA-N 1-amino-3-[[6-(3-chloroanilino)-9-ethylpurin-2-yl]amino]propan-2-ol Chemical compound N1=C(NCC(O)CN)N=C2N(CC)C=NC2=C1NC1=CC=CC(Cl)=C1 GXIHFMPIJZXDMF-UHFFFAOYSA-N 0.000 description 1
- GYSCBCSGKXNZRH-UHFFFAOYSA-N 1-benzothiophene-2-carboxamide Chemical compound C1=CC=C2SC(C(=O)N)=CC2=C1 GYSCBCSGKXNZRH-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- SATCOUWSAZBIJO-UHFFFAOYSA-N 1-methyladenine Natural products N=C1N(C)C=NC2=C1NC=N2 SATCOUWSAZBIJO-UHFFFAOYSA-N 0.000 description 1
- 125000004201 2,4-dichlorophenyl group Chemical group [H]C1=C([H])C(*)=C(Cl)C([H])=C1Cl 0.000 description 1
- IFNWESYYDINUHV-UHFFFAOYSA-N 2,6-dimethylpiperazine Chemical compound CC1CNCC(C)N1 IFNWESYYDINUHV-UHFFFAOYSA-N 0.000 description 1
- NMVIWTKSFKNTAK-UHFFFAOYSA-N 2-(3-aminopyrrolidin-1-yl)-n-(3-chlorophenyl)-9-ethylpurin-6-amine Chemical compound N1=C(N2CC(N)CC2)N=C2N(CC)C=NC2=C1NC1=CC=CC(Cl)=C1 NMVIWTKSFKNTAK-UHFFFAOYSA-N 0.000 description 1
- GVOYKJPMUUJXBS-UHFFFAOYSA-N 2-(aminomethyl)aniline Chemical compound NCC1=CC=CC=C1N GVOYKJPMUUJXBS-UHFFFAOYSA-N 0.000 description 1
- MGUMZJAQENFQKN-UHFFFAOYSA-N 2-(cyclohexylamino)ethanol Chemical compound OCCNC1CCCCC1 MGUMZJAQENFQKN-UHFFFAOYSA-N 0.000 description 1
- LBLYYCQCTBFVLH-UHFFFAOYSA-N 2-Methylbenzenesulfonic acid Chemical compound CC1=CC=CC=C1S(O)(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-N 0.000 description 1
- ZNDPQXWNARRVNA-UHFFFAOYSA-N 2-[[6-(3-chloroanilino)-9-ethylpurin-2-yl]-(2-hydroxyethyl)amino]ethanol Chemical compound N1=C(N(CCO)CCO)N=C2N(CC)C=NC2=C1NC1=CC=CC(Cl)=C1 ZNDPQXWNARRVNA-UHFFFAOYSA-N 0.000 description 1
- ZGGLJHWETDBVJL-UHFFFAOYSA-N 2-[[6-(3-chloroanilino)-9-ethylpurin-2-yl]-cyclohexylamino]ethanol Chemical compound N1=C(N(CCO)C2CCCCC2)N=C2N(CC)C=NC2=C1NC1=CC=CC(Cl)=C1 ZGGLJHWETDBVJL-UHFFFAOYSA-N 0.000 description 1
- SEIDORNQMFXILG-UHFFFAOYSA-N 2-[[6-(3-chloroanilino)-9-ethylpurin-2-yl]amino]-2-methylpropan-1-ol Chemical compound N1=C(NC(C)(C)CO)N=C2N(CC)C=NC2=C1NC1=CC=CC(Cl)=C1 SEIDORNQMFXILG-UHFFFAOYSA-N 0.000 description 1
- AYFOSKIMJSPZRM-UHFFFAOYSA-N 2-[[6-(3-chloroanilino)-9-ethylpurin-2-yl]amino]ethanol Chemical compound N1=C(NCCO)N=C2N(CC)C=NC2=C1NC1=CC=CC(Cl)=C1 AYFOSKIMJSPZRM-UHFFFAOYSA-N 0.000 description 1
- JNADEMSLZJQHRH-UHFFFAOYSA-N 2-[[6-(4-chloroanilino)-7-ethylpurin-2-yl]amino]ethanol Chemical compound C=12N(CC)C=NC2=NC(NCCO)=NC=1NC1=CC=C(Cl)C=C1 JNADEMSLZJQHRH-UHFFFAOYSA-N 0.000 description 1
- 229940058020 2-amino-2-methyl-1-propanol Drugs 0.000 description 1
- WKNMKGVLOWGGOU-UHFFFAOYSA-N 2-aminoacetamide;hydron;chloride Chemical compound Cl.NCC(N)=O WKNMKGVLOWGGOU-UHFFFAOYSA-N 0.000 description 1
- KJJPLEZQSCZCKE-UHFFFAOYSA-N 2-aminopropane-1,3-diol Chemical compound OCC(N)CO KJJPLEZQSCZCKE-UHFFFAOYSA-N 0.000 description 1
- 125000004974 2-butenyl group Chemical group C(C=CC)* 0.000 description 1
- UENGBOCGGKLVJJ-UHFFFAOYSA-N 2-chloro-1-(2,4-difluorophenyl)ethanone Chemical compound FC1=CC=C(C(=O)CCl)C(F)=C1 UENGBOCGGKLVJJ-UHFFFAOYSA-N 0.000 description 1
- SNBCBHDLGLDGRF-UHFFFAOYSA-N 2-chloro-9-ethylpurine Chemical compound N1=C(Cl)N=C2N(CC)C=NC2=C1 SNBCBHDLGLDGRF-UHFFFAOYSA-N 0.000 description 1
- SUHSVYQLBGBINJ-UHFFFAOYSA-N 2-chloro-n-(4-chlorophenyl)-9-ethylpurin-6-amine Chemical compound N1=C(Cl)N=C2N(CC)C=NC2=C1NC1=CC=C(Cl)C=C1 SUHSVYQLBGBINJ-UHFFFAOYSA-N 0.000 description 1
- DVBLPVYJSAJOFL-UHFFFAOYSA-N 2-chloro-n-(4-nitrophenyl)-7h-purin-6-amine Chemical compound C1=CC([N+](=O)[O-])=CC=C1NC1=NC(Cl)=NC2=C1NC=N2 DVBLPVYJSAJOFL-UHFFFAOYSA-N 0.000 description 1
- NYPGBHKJFKQTIY-TYYBGVCCSA-N 2-cyanoethylazanium;(e)-4-hydroxy-4-oxobut-2-enoate Chemical compound NCCC#N.OC(=O)\C=C\C(O)=O NYPGBHKJFKQTIY-TYYBGVCCSA-N 0.000 description 1
- WHUHSNFLWVKSNO-UHFFFAOYSA-N 2-hydrazinyl-n-(3-methoxyphenyl)-9-propan-2-ylpurin-6-amine;hydrochloride Chemical compound Cl.COC1=CC=CC(NC=2C=3N=CN(C=3N=C(NN)N=2)C(C)C)=C1 WHUHSNFLWVKSNO-UHFFFAOYSA-N 0.000 description 1
- QSECPQCFCWVBKM-UHFFFAOYSA-N 2-iodoethanol Chemical compound OCCI QSECPQCFCWVBKM-UHFFFAOYSA-N 0.000 description 1
- BJKIBONDVUBRBA-UHFFFAOYSA-N 2-n-(2-amino-2-methylpropyl)-6-n-(3-chlorophenyl)-9-ethylpurine-2,6-diamine;hydrochloride Chemical compound Cl.N1=C(NCC(C)(C)N)N=C2N(CC)C=NC2=C1NC1=CC=CC(Cl)=C1 BJKIBONDVUBRBA-UHFFFAOYSA-N 0.000 description 1
- PVFSTZZZDABUFA-UHFFFAOYSA-N 2-n-(2-aminoethyl)-9-ethyl-6-n-(3-nitrophenyl)purine-2,6-diamine;hydrochloride Chemical compound Cl.N1=C(NCCN)N=C2N(CC)C=NC2=C1NC1=CC=CC([N+]([O-])=O)=C1 PVFSTZZZDABUFA-UHFFFAOYSA-N 0.000 description 1
- SNSODEOPUYBSNZ-UHFFFAOYSA-N 2-n-(2-aminopropyl)-6-n-(3-chlorophenyl)-9-ethylpurine-2,6-diamine Chemical compound N1=C(NCC(C)N)N=C2N(CC)C=NC2=C1NC1=CC=CC(Cl)=C1 SNSODEOPUYBSNZ-UHFFFAOYSA-N 0.000 description 1
- YKCWAEXABPEYGZ-UHFFFAOYSA-N 2-n-(3-aminopropyl)-6-n-(3-chlorophenyl)-9-ethylpurine-2,6-diamine Chemical compound N1=C(NCCCN)N=C2N(CC)C=NC2=C1NC1=CC=CC(Cl)=C1 YKCWAEXABPEYGZ-UHFFFAOYSA-N 0.000 description 1
- WBAZNDSDRGWDGS-UHFFFAOYSA-N 2-n-(4-aminophenyl)-6-n-(3-chlorophenyl)-9-ethylpurine-2,6-diamine Chemical compound N1=C(NC=2C=CC(N)=CC=2)N=C2N(CC)C=NC2=C1NC1=CC=CC(Cl)=C1 WBAZNDSDRGWDGS-UHFFFAOYSA-N 0.000 description 1
- JXZIZOIXGMUPSK-HIFRSBDPSA-N 2-n-[(1s,3r)-3-aminocyclohexyl]-6-n-(3-chlorophenyl)-9-ethylpurine-2,6-diamine Chemical compound N1=C(N[C@@H]2C[C@H](N)CCC2)N=C2N(CC)C=NC2=C1NC1=CC=CC(Cl)=C1 JXZIZOIXGMUPSK-HIFRSBDPSA-N 0.000 description 1
- JLGNNDHMXJRZSW-UHFFFAOYSA-N 2-n-[(2-aminophenyl)methyl]-6-n-(3-chlorophenyl)-9-ethylpurine-2,6-diamine Chemical compound N1=C(NCC=2C(=CC=CC=2)N)N=C2N(CC)C=NC2=C1NC1=CC=CC(Cl)=C1 JLGNNDHMXJRZSW-UHFFFAOYSA-N 0.000 description 1
- BIRCXLPKGOKYHL-UHFFFAOYSA-N 2-n-benzyl-6-n-(3-chlorophenyl)-9-ethylpurine-2,6-diamine Chemical compound N1=C(NCC=2C=CC=CC=2)N=C2N(CC)C=NC2=C1NC1=CC=CC(Cl)=C1 BIRCXLPKGOKYHL-UHFFFAOYSA-N 0.000 description 1
- PKRSYEPBQPFNRB-UHFFFAOYSA-N 2-phenoxybenzoic acid Chemical compound OC(=O)C1=CC=CC=C1OC1=CC=CC=C1 PKRSYEPBQPFNRB-UHFFFAOYSA-N 0.000 description 1
- WLJVXDMOQOGPHL-PPJXEINESA-N 2-phenylacetic acid Chemical compound O[14C](=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-PPJXEINESA-N 0.000 description 1
- CJNRGSHEMCMUOE-UHFFFAOYSA-N 2-piperidin-1-ylethanamine Chemical compound NCCN1CCCCC1 CJNRGSHEMCMUOE-UHFFFAOYSA-N 0.000 description 1
- PXJBCMWIAPDWAU-UHFFFAOYSA-N 2-piperidin-4-ylethanamine Chemical compound NCCC1CCNCC1 PXJBCMWIAPDWAU-UHFFFAOYSA-N 0.000 description 1
- 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 description 1
- XPQIPUZPSLAZDV-UHFFFAOYSA-N 2-pyridylethylamine Chemical compound NCCC1=CC=CC=N1 XPQIPUZPSLAZDV-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- XEFRNCLPPFDWAC-UHFFFAOYSA-N 3,4,5-trimethoxyaniline Chemical compound COC1=CC(N)=CC(OC)=C1OC XEFRNCLPPFDWAC-UHFFFAOYSA-N 0.000 description 1
- IWPZKOJSYQZABD-UHFFFAOYSA-N 3,4,5-trimethoxybenzoic acid Natural products COC1=CC(OC)=CC(C(O)=O)=C1 IWPZKOJSYQZABD-UHFFFAOYSA-N 0.000 description 1
- RCGBOJKKKDETMV-UHFFFAOYSA-N 3-[(2-chloro-7h-purin-6-yl)amino]benzonitrile Chemical compound C=12NC=NC2=NC(Cl)=NC=1NC1=CC=CC(C#N)=C1 RCGBOJKKKDETMV-UHFFFAOYSA-N 0.000 description 1
- TWJBCIDYSBIBJI-UHFFFAOYSA-N 3-[[6-(3-chloroanilino)-9-ethylpurin-2-yl]amino]propanenitrile;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.N1=C(NCCC#N)N=C2N(CC)C=NC2=C1NC1=CC=CC(Cl)=C1 TWJBCIDYSBIBJI-UHFFFAOYSA-N 0.000 description 1
- NJXPYZHXZZCTNI-UHFFFAOYSA-N 3-aminobenzonitrile Chemical compound NC1=CC=CC(C#N)=C1 NJXPYZHXZZCTNI-UHFFFAOYSA-N 0.000 description 1
- 125000004975 3-butenyl group Chemical group C(CC=C)* 0.000 description 1
- PNPCRKVUWYDDST-UHFFFAOYSA-N 3-chloroaniline Chemical compound NC1=CC=CC(Cl)=C1 PNPCRKVUWYDDST-UHFFFAOYSA-N 0.000 description 1
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 1
- QZVQQUVWFIZUBQ-UHFFFAOYSA-N 3-fluoroaniline Chemical compound NC1=CC=CC(F)=C1 QZVQQUVWFIZUBQ-UHFFFAOYSA-N 0.000 description 1
- FAXDZWQIWUSWJH-UHFFFAOYSA-N 3-methoxypropan-1-amine Chemical compound COCCCN FAXDZWQIWUSWJH-UHFFFAOYSA-N 0.000 description 1
- JDQDSEVNMTYMOC-UHFFFAOYSA-N 3-methylbenzenesulfonic acid Chemical compound CC1=CC=CC(S(O)(=O)=O)=C1 JDQDSEVNMTYMOC-UHFFFAOYSA-N 0.000 description 1
- OSJPPGNTCRNQQC-UHFFFAOYSA-N 3-phosphoglyceric acid Chemical compound OC(=O)C(O)COP(O)(O)=O OSJPPGNTCRNQQC-UHFFFAOYSA-N 0.000 description 1
- 125000001999 4-Methoxybenzoyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1OC([H])([H])[H])C(*)=O 0.000 description 1
- KSMVBYPXNKCPAJ-UHFFFAOYSA-N 4-Methylcyclohexylamine Chemical compound CC1CCC(N)CC1 KSMVBYPXNKCPAJ-UHFFFAOYSA-N 0.000 description 1
- WUBBRNOQWQTFEX-UHFFFAOYSA-N 4-aminosalicylic acid Chemical compound NC1=CC=C(C(O)=O)C(O)=C1 WUBBRNOQWQTFEX-UHFFFAOYSA-N 0.000 description 1
- QSNSCYSYFYORTR-UHFFFAOYSA-N 4-chloroaniline Chemical compound NC1=CC=C(Cl)C=C1 QSNSCYSYFYORTR-UHFFFAOYSA-N 0.000 description 1
- 125000000242 4-chlorobenzoyl group Chemical group ClC1=CC=C(C(=O)*)C=C1 0.000 description 1
- KRZCOLNOCZKSDF-UHFFFAOYSA-N 4-fluoroaniline Chemical compound NC1=CC=C(F)C=C1 KRZCOLNOCZKSDF-UHFFFAOYSA-N 0.000 description 1
- TYMLOMAKGOJONV-UHFFFAOYSA-N 4-nitroaniline Chemical compound NC1=CC=C([N+]([O-])=O)C=C1 TYMLOMAKGOJONV-UHFFFAOYSA-N 0.000 description 1
- MGYGFNQQGAQEON-UHFFFAOYSA-N 4-tolyl isocyanate Chemical compound CC1=CC=C(N=C=O)C=C1 MGYGFNQQGAQEON-UHFFFAOYSA-N 0.000 description 1
- ODGIMMLDVSWADK-UHFFFAOYSA-N 4-trifluoromethylaniline Chemical compound NC1=CC=C(C(F)(F)F)C=C1 ODGIMMLDVSWADK-UHFFFAOYSA-N 0.000 description 1
- ASPDJZINBYYZRU-UHFFFAOYSA-N 5-amino-2-chlorobenzotrifluoride Chemical compound NC1=CC=C(Cl)C(C(F)(F)F)=C1 ASPDJZINBYYZRU-UHFFFAOYSA-N 0.000 description 1
- 125000004008 6 membered carbocyclic group Chemical group 0.000 description 1
- LOFIILORZZPNJZ-UHFFFAOYSA-N 6-n-(3-chlorophenyl)-9-ethyl-2-n-(2-phenylethyl)purine-2,6-diamine Chemical compound N1=C(NCCC=2C=CC=CC=2)N=C2N(CC)C=NC2=C1NC1=CC=CC(Cl)=C1 LOFIILORZZPNJZ-UHFFFAOYSA-N 0.000 description 1
- MTDAEZPBWCIBMA-UHFFFAOYSA-N 6-n-(3-chlorophenyl)-9-ethyl-2-n-(2-piperidin-1-ylethyl)purine-2,6-diamine Chemical compound N1=C(NCCN2CCCCC2)N=C2N(CC)C=NC2=C1NC1=CC=CC(Cl)=C1 MTDAEZPBWCIBMA-UHFFFAOYSA-N 0.000 description 1
- GPEGGWAQXTULQR-UHFFFAOYSA-N 6-n-(3-chlorophenyl)-9-ethyl-2-n-(2-pyridin-2-ylethyl)purine-2,6-diamine Chemical compound N1=C(NCCC=2N=CC=CC=2)N=C2N(CC)C=NC2=C1NC1=CC=CC(Cl)=C1 GPEGGWAQXTULQR-UHFFFAOYSA-N 0.000 description 1
- WGAIFNIDPKZISJ-UHFFFAOYSA-N 6-n-(3-chlorophenyl)-9-ethyl-2-n-(3-methoxypropyl)purine-2,6-diamine Chemical compound N1=C(NCCCOC)N=C2N(CC)C=NC2=C1NC1=CC=CC(Cl)=C1 WGAIFNIDPKZISJ-UHFFFAOYSA-N 0.000 description 1
- SURLGSWLCHIHPZ-UHFFFAOYSA-N 6-n-(3-chlorophenyl)-9-ethyl-2-n-(oxolan-2-ylmethyl)purine-2,6-diamine Chemical compound N1=C(NCC2OCCC2)N=C2N(CC)C=NC2=C1NC1=CC=CC(Cl)=C1 SURLGSWLCHIHPZ-UHFFFAOYSA-N 0.000 description 1
- 125000005330 8 membered heterocyclic group Chemical group 0.000 description 1
- CYJRNFFLTBEQSQ-UHFFFAOYSA-N 8-(3-methyl-1-benzothiophen-5-yl)-N-(4-methylsulfonylpyridin-3-yl)quinoxalin-6-amine Chemical compound CS(=O)(=O)C1=C(C=NC=C1)NC=1C=C2N=CC=NC2=C(C=1)C=1C=CC2=C(C(=CS2)C)C=1 CYJRNFFLTBEQSQ-UHFFFAOYSA-N 0.000 description 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- WDJHALXBUFZDSR-UHFFFAOYSA-N Acetoacetic acid Natural products CC(=O)CC(O)=O WDJHALXBUFZDSR-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 235000019489 Almond oil Nutrition 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 101100331289 Aquifex aeolicus (strain VF5) der gene Proteins 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 241000258957 Asteroidea Species 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- 206010005003 Bladder cancer Diseases 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- 102000001840 CDC2-CDC28 Kinases Human genes 0.000 description 1
- 108010040340 CDC2-CDC28 Kinases Proteins 0.000 description 1
- DTPPNWDAZYXHQL-UHFFFAOYSA-N COCC[O] Chemical compound COCC[O] DTPPNWDAZYXHQL-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- AEMOLEFTQBMNLQ-YMDCURPLSA-N D-galactopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-YMDCURPLSA-N 0.000 description 1
- DSLZVSRJTYRBFB-LLEIAEIESA-N D-glucaric acid Chemical compound OC(=O)[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O DSLZVSRJTYRBFB-LLEIAEIESA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 description 1
- HVVNJUAVDAZWCB-RXMQYKEDSA-N D-prolinol Chemical compound OC[C@H]1CCCN1 HVVNJUAVDAZWCB-RXMQYKEDSA-N 0.000 description 1
- GHVNFZFCNZKVNT-UHFFFAOYSA-N Decanoic acid Natural products CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- RPNUMPOLZDHAAY-UHFFFAOYSA-N Diethylenetriamine Chemical compound NCCNCCN RPNUMPOLZDHAAY-UHFFFAOYSA-N 0.000 description 1
- 101100456896 Drosophila melanogaster metl gene Proteins 0.000 description 1
- 239000006145 Eagle's minimal essential medium Substances 0.000 description 1
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
- 241001337814 Erysiphe glycines Species 0.000 description 1
- KIWBPDUYBMNFTB-UHFFFAOYSA-N Ethyl hydrogen sulfate Chemical compound CCOS(O)(=O)=O KIWBPDUYBMNFTB-UHFFFAOYSA-N 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical group C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical class F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 1
- 230000010190 G1 phase Effects 0.000 description 1
- 230000005526 G1 to G0 transition Effects 0.000 description 1
- DSLZVSRJTYRBFB-UHFFFAOYSA-N Galactaric acid Natural products OC(=O)C(O)C(O)C(O)C(O)C(O)=O DSLZVSRJTYRBFB-UHFFFAOYSA-N 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- DHCLVCXQIBBOPH-UHFFFAOYSA-N Glycerol 2-phosphate Chemical compound OCC(CO)OP(O)(O)=O DHCLVCXQIBBOPH-UHFFFAOYSA-N 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 1
- 108010033040 Histones Proteins 0.000 description 1
- 102000006947 Histones Human genes 0.000 description 1
- 102000003839 Human Proteins Human genes 0.000 description 1
- 108090000144 Human Proteins Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- PIWKPBJCKXDKJR-UHFFFAOYSA-N Isoflurane Chemical compound FC(F)OC(Cl)C(F)(F)F PIWKPBJCKXDKJR-UHFFFAOYSA-N 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ZGUNAGUHMKGQNY-ZETCQYMHSA-N L-alpha-phenylglycine zwitterion Chemical compound OC(=O)[C@@H](N)C1=CC=CC=C1 ZGUNAGUHMKGQNY-ZETCQYMHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- VLJNHYLEOZPXFW-BYPYZUCNSA-N L-prolinamide Chemical compound NC(=O)[C@@H]1CCCN1 VLJNHYLEOZPXFW-BYPYZUCNSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 235000019759 Maize starch Nutrition 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
- 101100355956 Mus musculus Rdh7 gene Proteins 0.000 description 1
- HXFOXFJUNFFYMO-BYPYZUCNSA-N N-alpha-acetyl-L-asparagine Chemical compound CC(=O)N[C@H](C(O)=O)CC(N)=O HXFOXFJUNFFYMO-BYPYZUCNSA-N 0.000 description 1
- HTLZVHNRZJPSMI-UHFFFAOYSA-N N-ethylpiperidine Chemical compound CCN1CCCCC1 HTLZVHNRZJPSMI-UHFFFAOYSA-N 0.000 description 1
- 101100513046 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) eth-1 gene Proteins 0.000 description 1
- BZQFBWGGLXLEPQ-UHFFFAOYSA-N O-phosphoryl-L-serine Natural products OC(=O)C(N)COP(O)(O)=O BZQFBWGGLXLEPQ-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
- 108010077895 Sarcosine Proteins 0.000 description 1
- 229920002684 Sepharose Polymers 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- NWGKJDSIEKMTRX-AAZCQSIUSA-N Sorbitan monooleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-AAZCQSIUSA-N 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- FGUZFFWTBWJBIL-XWVZOOPGSA-N [(1r)-1-[(2s,3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)O[C@H](CO)[C@H]1OC[C@H](O)[C@H]1O FGUZFFWTBWJBIL-XWVZOOPGSA-N 0.000 description 1
- SMEGJBVQLJJKKX-HOTMZDKISA-N [(2R,3S,4S,5R,6R)-5-acetyloxy-3,4,6-trihydroxyoxan-2-yl]methyl acetate Chemical compound CC(=O)OC[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)O)OC(=O)C)O)O SMEGJBVQLJJKKX-HOTMZDKISA-N 0.000 description 1
- INOQUZXUCBEROH-CQSZACIVSA-N [(2r)-1-[6-(3-chloroanilino)-9-ethylpurin-2-yl]pyrrolidin-2-yl]methanol Chemical compound N1=C(N2[C@H](CCC2)CO)N=C2N(CC)C=NC2=C1NC1=CC=CC(Cl)=C1 INOQUZXUCBEROH-CQSZACIVSA-N 0.000 description 1
- FIAINKIUSZGVGX-DKWTVANSSA-N [(2s)-1-amino-1-oxopropan-2-yl]azanium;chloride Chemical compound Cl.C[C@H](N)C(N)=O FIAINKIUSZGVGX-DKWTVANSSA-N 0.000 description 1
- HVVNJUAVDAZWCB-YFKPBYRVSA-N [(2s)-pyrrolidin-2-yl]methanol Chemical compound OC[C@@H]1CCCN1 HVVNJUAVDAZWCB-YFKPBYRVSA-N 0.000 description 1
- QDPORLAESROAMV-UHFFFAOYSA-N [1-[[6-(3-chloroanilino)-9-ethylpurin-2-yl]amino]cyclopentyl]methanol Chemical compound N1=C(NC2(CO)CCCC2)N=C2N(CC)C=NC2=C1NC1=CC=CC(Cl)=C1 QDPORLAESROAMV-UHFFFAOYSA-N 0.000 description 1
- KVRNFWIMPWXLBS-UHFFFAOYSA-N [2-[6-(3-chloroanilino)-9-ethylpurin-2-yl]-1H-imidazol-5-yl]methanol Chemical compound N1=C(C=2NC=C(CO)N=2)N=C2N(CC)C=NC2=C1NC1=CC=CC(Cl)=C1 KVRNFWIMPWXLBS-UHFFFAOYSA-N 0.000 description 1
- FDLQZKYLHJJBHD-UHFFFAOYSA-N [3-(aminomethyl)phenyl]methanamine Chemical compound NCC1=CC=CC(CN)=C1 FDLQZKYLHJJBHD-UHFFFAOYSA-N 0.000 description 1
- XQAXGZLFSSPBMK-UHFFFAOYSA-M [7-(dimethylamino)phenothiazin-3-ylidene]-dimethylazanium;chloride;trihydrate Chemical compound O.O.O.[Cl-].C1=CC(=[N+](C)C)C=C2SC3=CC(N(C)C)=CC=C3N=C21 XQAXGZLFSSPBMK-UHFFFAOYSA-M 0.000 description 1
- OCBFFGCSTGGPSQ-UHFFFAOYSA-N [CH2]CC Chemical class [CH2]CC OCBFFGCSTGGPSQ-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 229940081735 acetylcellulose Drugs 0.000 description 1
- 229960004308 acetylcysteine Drugs 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- JIMXXGFJRDUSRO-UHFFFAOYSA-N adamantane-1-carboxylic acid Chemical compound C1C(C2)CC3CC2CC1(C(=O)O)C3 JIMXXGFJRDUSRO-UHFFFAOYSA-N 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 125000000304 alkynyl group Chemical group 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- OBETXYAYXDNJHR-UHFFFAOYSA-N alpha-ethylcaproic acid Natural products CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 229910000323 aluminium silicate Inorganic materials 0.000 description 1
- IMUDHTPIFIBORV-UHFFFAOYSA-N aminoethylpiperazine Chemical compound NCCN1CCNCC1 IMUDHTPIFIBORV-UHFFFAOYSA-N 0.000 description 1
- CBTVGIZVANVGBH-UHFFFAOYSA-N aminomethyl propanol Chemical compound CC(C)(N)CO CBTVGIZVANVGBH-UHFFFAOYSA-N 0.000 description 1
- 229960004909 aminosalicylic acid Drugs 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 238000001949 anaesthesia Methods 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000001028 anti-proliverative effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000009697 arginine Nutrition 0.000 description 1
- 125000003435 aroyl group Chemical group 0.000 description 1
- 125000005239 aroylamino group Chemical group 0.000 description 1
- 125000003710 aryl alkyl group Chemical group 0.000 description 1
- 125000005101 aryl methoxy carbonyl group Chemical group 0.000 description 1
- 125000005161 aryl oxy carbonyl group Chemical group 0.000 description 1
- 125000005110 aryl thio group Chemical group 0.000 description 1
- 125000004104 aryloxy group Chemical group 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 238000000065 atmospheric pressure chemical ionisation Methods 0.000 description 1
- 150000001540 azides Chemical class 0.000 description 1
- 125000003828 azulenyl group Chemical group 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- 229940092714 benzenesulfonic acid Drugs 0.000 description 1
- FHRRJZZGSJXPRQ-UHFFFAOYSA-N benzyl phenylmethoxycarbonyl carbonate Chemical compound C=1C=CC=CC=1COC(=O)OC(=O)OCC1=CC=CC=C1 FHRRJZZGSJXPRQ-UHFFFAOYSA-N 0.000 description 1
- 125000002619 bicyclic group Chemical group 0.000 description 1
- 201000001531 bladder carcinoma Diseases 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 125000000707 boryl group Chemical group B* 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 125000000480 butynyl group Chemical group [*]C#CC([H])([H])C([H])([H])[H] 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- HNEGQIOMVPPMNR-IHWYPQMZSA-N citraconic acid Chemical compound OC(=O)C(/C)=C\C(O)=O HNEGQIOMVPPMNR-IHWYPQMZSA-N 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 239000007859 condensation product Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- GEQHKFFSPGPGLN-UHFFFAOYSA-N cyclohexane-1,3-diamine Chemical compound NC1CCCC(N)C1 GEQHKFFSPGPGLN-UHFFFAOYSA-N 0.000 description 1
- VKIRRGRTJUUZHS-UHFFFAOYSA-N cyclohexane-1,4-diamine Chemical compound NC1CCC(N)CC1 VKIRRGRTJUUZHS-UHFFFAOYSA-N 0.000 description 1
- HCAJEUSONLESMK-UHFFFAOYSA-N cyclohexylsulfamic acid Chemical compound OS(=O)(=O)NC1CCCCC1 HCAJEUSONLESMK-UHFFFAOYSA-N 0.000 description 1
- OOTFVKOQINZBBF-UHFFFAOYSA-N cystamine Chemical compound CCSSCCN OOTFVKOQINZBBF-UHFFFAOYSA-N 0.000 description 1
- 229940099500 cystamine Drugs 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 230000021953 cytokinesis Effects 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 229950006137 dexfosfoserine Drugs 0.000 description 1
- WOWBFOBYOAGEEA-UHFFFAOYSA-N diafenthiuron Chemical compound CC(C)C1=C(NC(=S)NC(C)(C)C)C(C(C)C)=CC(OC=2C=CC=CC=2)=C1 WOWBFOBYOAGEEA-UHFFFAOYSA-N 0.000 description 1
- HTFFABIIOAKIBH-UHFFFAOYSA-N diazinane Chemical compound C1CCNNC1 HTFFABIIOAKIBH-UHFFFAOYSA-N 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- 229940087091 dichlorotetrafluoroethane Drugs 0.000 description 1
- 125000001664 diethylamino group Chemical group [H]C([H])([H])C([H])([H])N(*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940043279 diisopropylamine Drugs 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 1
- UXGNZZKBCMGWAZ-UHFFFAOYSA-N dimethylformamide dmf Chemical compound CN(C)C=O.CN(C)C=O UXGNZZKBCMGWAZ-UHFFFAOYSA-N 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- GRWZHXKQBITJKP-UHFFFAOYSA-L dithionite(2-) Chemical compound [O-]S(=O)S([O-])=O GRWZHXKQBITJKP-UHFFFAOYSA-L 0.000 description 1
- CETRZFQIITUQQL-UHFFFAOYSA-N dmso dimethylsulfoxide Chemical compound CS(C)=O.CS(C)=O CETRZFQIITUQQL-UHFFFAOYSA-N 0.000 description 1
- LLRANSBEYQZKFY-UHFFFAOYSA-N dodecanoic acid;propane-1,2-diol Chemical compound CC(O)CO.CCCCCCCCCCCC(O)=O LLRANSBEYQZKFY-UHFFFAOYSA-N 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
- 239000006196 drop Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- AFAXGSQYZLGZPG-UHFFFAOYSA-N ethanedisulfonic acid Chemical compound OS(=O)(=O)CCS(O)(=O)=O AFAXGSQYZLGZPG-UHFFFAOYSA-N 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- FPIQZBQZKBKLEI-UHFFFAOYSA-N ethyl 1-[[2-chloroethyl(nitroso)carbamoyl]amino]cyclohexane-1-carboxylate Chemical compound ClCCN(N=O)C(=O)NC1(C(=O)OCC)CCCCC1 FPIQZBQZKBKLEI-UHFFFAOYSA-N 0.000 description 1
- RZDRJEHTKWQFQO-UHFFFAOYSA-N ethyl 3-amino-2-methylbenzoate Chemical compound CCOC(=O)C1=CC=CC(N)=C1C RZDRJEHTKWQFQO-UHFFFAOYSA-N 0.000 description 1
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
- 229940093471 ethyl oleate Drugs 0.000 description 1
- SIVVHUQWDOGLJN-UHFFFAOYSA-N ethylsulfamic acid Chemical group CCNS(O)(=O)=O SIVVHUQWDOGLJN-UHFFFAOYSA-N 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000010265 fast atom bombardment Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 238000001640 fractional crystallisation Methods 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- DDRPCXLAQZKBJP-UHFFFAOYSA-N furfurylamine Chemical compound NCC1=CC=CO1 DDRPCXLAQZKBJP-UHFFFAOYSA-N 0.000 description 1
- DSLZVSRJTYRBFB-DUHBMQHGSA-N galactaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(O)=O DSLZVSRJTYRBFB-DUHBMQHGSA-N 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000005227 gel permeation chromatography Methods 0.000 description 1
- 230000008570 general process Effects 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 235000004554 glutamine Nutrition 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 1
- 235000014304 histidine Nutrition 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 150000004677 hydrates Chemical class 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- WFNASTYGEKUMIY-UHFFFAOYSA-N hydron;1h-imidazol-5-ylmethanol;chloride Chemical compound Cl.OCC1=CN=CN1 WFNASTYGEKUMIY-UHFFFAOYSA-N 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 150000002440 hydroxy compounds Chemical class 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 229940031704 hydroxypropyl methylcellulose phthalate Drugs 0.000 description 1
- 229920003132 hydroxypropyl methylcellulose phthalate Polymers 0.000 description 1
- VKOBVWXKNCXXDE-UHFFFAOYSA-N icosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCC(O)=O VKOBVWXKNCXXDE-UHFFFAOYSA-N 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000003978 infusion fluid Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000003049 inorganic solvent Substances 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 229960002725 isoflurane Drugs 0.000 description 1
- 125000004491 isohexyl group Chemical group C(CCC(C)C)* 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 235000014705 isoleucine Nutrition 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000000555 isopropenyl group Chemical group [H]\C([H])=C(\*)C([H])([H])[H] 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 125000000842 isoxazolyl group Chemical group 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 235000005772 leucine Nutrition 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 235000014666 liquid concentrate Nutrition 0.000 description 1
- 235000018977 lysine Nutrition 0.000 description 1
- NCBZRJODKRCREW-UHFFFAOYSA-N m-anisidine Chemical compound COC1=CC=CC(N)=C1 NCBZRJODKRCREW-UHFFFAOYSA-N 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 235000009973 maize Nutrition 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229960002510 mandelic acid Drugs 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 235000006109 methionine Nutrition 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- JZMJDSHXVKJFKW-UHFFFAOYSA-N methyl sulfate Chemical compound COS(O)(=O)=O JZMJDSHXVKJFKW-UHFFFAOYSA-N 0.000 description 1
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 229960002900 methylcellulose Drugs 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 description 1
- 229960000907 methylthioninium chloride Drugs 0.000 description 1
- 230000003641 microbiacidal effect Effects 0.000 description 1
- 229940124561 microbicide Drugs 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- KFIGICHILYTCJF-UHFFFAOYSA-N n'-methylethane-1,2-diamine Chemical compound CNCCN KFIGICHILYTCJF-UHFFFAOYSA-N 0.000 description 1
- KIDSRUSWXRTAQB-UHFFFAOYSA-N n-(3-chlorophenyl)-2-(1,4-dioxa-8-azaspiro[4.5]decan-8-yl)-9-ethylpurin-6-amine Chemical compound N1=C(N2CCC3(CC2)OCCO3)N=C2N(CC)C=NC2=C1NC1=CC=CC(Cl)=C1 KIDSRUSWXRTAQB-UHFFFAOYSA-N 0.000 description 1
- OPFNFWPLKVBIJQ-UHFFFAOYSA-N n-(3-chlorophenyl)-2-(2,6-dimethylpiperazin-1-yl)-9-ethylpurin-6-amine Chemical compound N1=C(N2C(CNCC2C)C)N=C2N(CC)C=NC2=C1NC1=CC=CC(Cl)=C1 OPFNFWPLKVBIJQ-UHFFFAOYSA-N 0.000 description 1
- IAMDFLHGUWFHDA-UHFFFAOYSA-N n-(3-chlorophenyl)-9-ethyl-2-imidazol-1-ylpurin-6-amine Chemical compound N1=C(N2C=NC=C2)N=C2N(CC)C=NC2=C1NC1=CC=CC(Cl)=C1 IAMDFLHGUWFHDA-UHFFFAOYSA-N 0.000 description 1
- MTBIOSFNHXZJOV-UHFFFAOYSA-N n-(3-chlorophenyl)-9-ethyl-2-piperidin-1-ylpurin-6-amine Chemical compound N1=C(N2CCCCC2)N=C2N(CC)C=NC2=C1NC1=CC=CC(Cl)=C1 MTBIOSFNHXZJOV-UHFFFAOYSA-N 0.000 description 1
- HEYOYIAHGVAVHO-UHFFFAOYSA-N n-[2-[[6-(3-chloroanilino)-9-ethylpurin-2-yl]amino]ethyl]acetamide Chemical compound N1=C(NCCNC(C)=O)N=C2N(CC)C=NC2=C1NC1=CC=CC(Cl)=C1 HEYOYIAHGVAVHO-UHFFFAOYSA-N 0.000 description 1
- XDVCVADNEULMOZ-UHFFFAOYSA-N n-[3,5-bis(trifluoromethyl)phenyl]-2-chloro-7h-purin-6-amine Chemical compound FC(F)(F)C1=CC(C(F)(F)F)=CC(NC=2C=3NC=NC=3N=C(Cl)N=2)=C1 XDVCVADNEULMOZ-UHFFFAOYSA-N 0.000 description 1
- RWIVICVCHVMHMU-UHFFFAOYSA-N n-aminoethylmorpholine Chemical compound NCCN1CCOCC1 RWIVICVCHVMHMU-UHFFFAOYSA-N 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000003136 n-heptyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- KVBGVZZKJNLNJU-UHFFFAOYSA-N naphthalene-2-sulfonic acid Chemical compound C1=CC=CC2=CC(S(=O)(=O)O)=CC=C21 KVBGVZZKJNLNJU-UHFFFAOYSA-N 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 150000002826 nitrites Chemical class 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 230000000269 nucleophilic effect Effects 0.000 description 1
- YTJSFYQNRXLOIC-UHFFFAOYSA-N octadecylsilane Chemical class CCCCCCCCCCCCCCCCCC[SiH3] YTJSFYQNRXLOIC-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- YNOGYQAEJGADFJ-UHFFFAOYSA-N oxolan-2-ylmethanamine Chemical compound NCC1CCCO1 YNOGYQAEJGADFJ-UHFFFAOYSA-N 0.000 description 1
- 125000003232 p-nitrobenzoyl group Chemical group [N+](=O)([O-])C1=CC=C(C(=O)*)C=C1 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 238000004810 partition chromatography Methods 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical class OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 1
- 229940083251 peripheral vasodilators purine derivative Drugs 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- PSBAIJVSCTZDDB-UHFFFAOYSA-N phenyl acetylsalicylate Chemical compound CC(=O)OC1=CC=CC=C1C(=O)OC1=CC=CC=C1 PSBAIJVSCTZDDB-UHFFFAOYSA-N 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 235000008729 phenylalanine Nutrition 0.000 description 1
- BZQFBWGGLXLEPQ-REOHCLBHSA-N phosphoserine Chemical compound OC(=O)[C@@H](N)COP(O)(O)=O BZQFBWGGLXLEPQ-REOHCLBHSA-N 0.000 description 1
- 238000006303 photolysis reaction Methods 0.000 description 1
- 230000015843 photosynthesis, light reaction Effects 0.000 description 1
- XNGIFLGASWRNHJ-UHFFFAOYSA-L phthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-L 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical class OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- IYPZRUYMFDWKSS-UHFFFAOYSA-N piperazin-1-amine Chemical compound NN1CCNCC1 IYPZRUYMFDWKSS-UHFFFAOYSA-N 0.000 description 1
- PRAYXGYYVXRDDW-UHFFFAOYSA-N piperidin-2-ylmethanol Chemical compound OCC1CCCCN1 PRAYXGYYVXRDDW-UHFFFAOYSA-N 0.000 description 1
- GGPNYXIOFZLNKW-UHFFFAOYSA-N piperidin-3-amine;dihydrochloride Chemical compound Cl.Cl.NC1CCCNC1 GGPNYXIOFZLNKW-UHFFFAOYSA-N 0.000 description 1
- HDOWRFHMPULYOA-UHFFFAOYSA-N piperidin-4-ol Chemical compound OC1CCNCC1 HDOWRFHMPULYOA-UHFFFAOYSA-N 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 229920001592 potato starch Polymers 0.000 description 1
- 229940116317 potato starch Drugs 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 235000013930 proline Nutrition 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 125000004368 propenyl group Chemical group C(=CC)* 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
- AOHJOMMDDJHIJH-UHFFFAOYSA-N propylenediamine Chemical compound CC(N)CN AOHJOMMDDJHIJH-UHFFFAOYSA-N 0.000 description 1
- HLIBNTOXKQCYMV-UHFFFAOYSA-N propylsulfamic acid Chemical compound CCCNS(O)(=O)=O HLIBNTOXKQCYMV-UHFFFAOYSA-N 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000001944 prunus armeniaca kernel oil Substances 0.000 description 1
- 150000003212 purines Chemical class 0.000 description 1
- NJPNCMOUEXEGBL-UHFFFAOYSA-N pyrrolidin-1-ium-3-ylazanium;dichloride Chemical compound Cl.Cl.NC1CCNC1 NJPNCMOUEXEGBL-UHFFFAOYSA-N 0.000 description 1
- 229940107700 pyruvic acid Drugs 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 229940100486 rice starch Drugs 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 235000003441 saturated fatty acids Nutrition 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 235000004400 serine Nutrition 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- XGVXKJKTISMIOW-ZDUSSCGKSA-N simurosertib Chemical compound N1N=CC(C=2SC=3C(=O)NC(=NC=3C=2)[C@H]2N3CCC(CC3)C2)=C1C XGVXKJKTISMIOW-ZDUSSCGKSA-N 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- JVBXVOWTABLYPX-UHFFFAOYSA-L sodium dithionite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])=O JVBXVOWTABLYPX-UHFFFAOYSA-L 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- RMBAVIFYHOYIFM-UHFFFAOYSA-M sodium methanethiolate Chemical compound [Na+].[S-]C RMBAVIFYHOYIFM-UHFFFAOYSA-M 0.000 description 1
- RBWSWDPRDBEWCR-RKJRWTFHSA-N sodium;(2r)-2-[(2r)-3,4-dihydroxy-5-oxo-2h-furan-2-yl]-2-hydroxyethanolate Chemical compound [Na+].[O-]C[C@@H](O)[C@H]1OC(=O)C(O)=C1O RBWSWDPRDBEWCR-RKJRWTFHSA-N 0.000 description 1
- RZWQDAUIUBVCDD-UHFFFAOYSA-M sodium;benzenethiolate Chemical compound [Na+].[S-]C1=CC=CC=C1 RZWQDAUIUBVCDD-UHFFFAOYSA-M 0.000 description 1
- NWZBFJYXRGSRGD-UHFFFAOYSA-M sodium;octadecyl sulfate Chemical compound [Na+].CCCCCCCCCCCCCCCCCCOS([O-])(=O)=O NWZBFJYXRGSRGD-UHFFFAOYSA-M 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 229940057429 sorbitan isostearate Drugs 0.000 description 1
- 229950004959 sorbitan oleate Drugs 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 125000000446 sulfanediyl group Chemical group *S* 0.000 description 1
- 150000003462 sulfoxides Chemical class 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 239000002700 tablet coating Substances 0.000 description 1
- 238000009492 tablet coating Methods 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 125000004213 tert-butoxy group Chemical group [H]C([H])([H])C(O*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000006633 tert-butoxycarbonylamino group Chemical group 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- WHRNULOCNSKMGB-UHFFFAOYSA-N tetrahydrofuran thf Chemical compound C1CCOC1.C1CCOC1 WHRNULOCNSKMGB-UHFFFAOYSA-N 0.000 description 1
- WROMPOXWARCANT-UHFFFAOYSA-N tfa trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.OC(=O)C(F)(F)F WROMPOXWARCANT-UHFFFAOYSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 125000000335 thiazolyl group Chemical group 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 125000005505 thiomorpholino group Chemical group 0.000 description 1
- 235000008521 threonine Nutrition 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 229940078499 tricalcium phosphate Drugs 0.000 description 1
- 235000019731 tricalcium phosphate Nutrition 0.000 description 1
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 1
- ILWRPSCZWQJDMK-UHFFFAOYSA-N triethylazanium;chloride Chemical compound Cl.CCN(CC)CC ILWRPSCZWQJDMK-UHFFFAOYSA-N 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 150000004072 triols Chemical class 0.000 description 1
- 238000001665 trituration Methods 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 208000010570 urinary bladder carcinoma Diseases 0.000 description 1
- 235000014393 valine Nutrition 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/16—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH3094/95 | 1995-11-01 | ||
| CH309495 | 1995-11-01 | ||
| CH2213/96 | 1996-09-10 | ||
| CH221396 | 1996-09-10 | ||
| PCT/EP1996/004573 WO1997016452A1 (en) | 1995-11-01 | 1996-10-22 | Purine derivatives and processes for their preparation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2234609A1 CA2234609A1 (en) | 1997-05-09 |
| CA2234609C true CA2234609C (en) | 2006-11-28 |
Family
ID=25689809
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002234609A Expired - Fee Related CA2234609C (en) | 1995-11-01 | 1996-10-22 | 2-amino-6-anilino-purine derivatives and processes for their preparation |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US7091346B1 (https=) |
| EP (1) | EP0874846B1 (https=) |
| JP (2) | JP4004066B2 (https=) |
| CN (1) | CN1066147C (https=) |
| AR (1) | AR004134A1 (https=) |
| AT (1) | ATE236161T1 (https=) |
| AU (1) | AU7296896A (https=) |
| BR (1) | BR9611157A (https=) |
| CA (1) | CA2234609C (https=) |
| DE (1) | DE69627195T2 (https=) |
| ES (1) | ES2196181T3 (https=) |
| PT (1) | PT874846E (https=) |
| WO (1) | WO1997016452A1 (https=) |
Families Citing this family (59)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2741881B1 (fr) | 1995-12-01 | 1999-07-30 | Centre Nat Rech Scient | Nouveaux derives de purine possedant notamment des prorietes anti-proliferatives et leurs applications biologiques |
| US6794390B2 (en) * | 1996-08-02 | 2004-09-21 | Cv Therapeutics, Inc. | Purine inhibitors of cyclin dependent kinase 2 & ikappabalpha |
| US6790958B2 (en) * | 1996-08-02 | 2004-09-14 | Robert T. Lum | Purine inhibitors of cyclin dependent kinase 2 & IKBA |
| US5866702A (en) * | 1996-08-02 | 1999-02-02 | Cv Therapeutics, Incorporation | Purine inhibitors of cyclin dependent kinase 2 |
| AU4920397A (en) * | 1996-10-11 | 1998-05-11 | Chiron Corporation | Purine inhibitors of glycogen synthase kinase 3 (gsk3) |
| US6432947B1 (en) * | 1997-02-19 | 2002-08-13 | Berlex Laboratories, Inc. | N-heterocyclic derivatives as NOS inhibitors |
| CA2297967A1 (en) | 1997-08-07 | 1999-02-18 | The Regents Of The University Of California | Purine inhibitor of protein kinases, g proteins and polymerases |
| US6573044B1 (en) | 1997-08-07 | 2003-06-03 | The Regents Of The University Of California | Methods of using chemical libraries to search for new kinase inhibitors |
| NZ503788A (en) | 1997-10-27 | 2002-11-26 | Agouron Pharma | 4-aminothiazole derivatives and their use as inhibitors of cyclin-dependent kinases |
| AU1631699A (en) * | 1997-12-18 | 1999-07-05 | E.I. Du Pont De Nemours And Company | Cyclohexylamine arthropodicides and fungicides |
| US6642231B2 (en) * | 1998-02-26 | 2003-11-04 | Aventis Pharmaceuticals Inc. | 6,9-disubstituted 2-[trans-(4-aminocyclohexyl)amino] purines |
| DE69912248T2 (de) * | 1998-02-26 | 2004-04-22 | Aventis Pharmaceuticals Inc. | 6,9-disubstituierte 2-[trans-(4-aminocyclohexyl)amino] purine |
| US6479487B1 (en) * | 1998-02-26 | 2002-11-12 | Aventis Pharmaceuticals Inc. | 6, 9-disubstituted 2-[trans-(4-aminocyclohexyl)amino] purines |
| US6413974B1 (en) * | 1998-02-26 | 2002-07-02 | Aventis Pharmaceuticals Inc. | 6,9,-disubstituted 2-[trans-(4-aminocyclohexyl) amino] purines |
| IL138044A0 (en) * | 1998-02-26 | 2001-10-31 | Aventis Pharma Inc | 6,9-disubstituted 2-[trans- 4-aminocyclohexyl) amino] purines |
| CZ27399A3 (cs) * | 1999-01-26 | 2000-08-16 | Ústav Experimentální Botaniky Av Čr | Substituované dusíkaté heterocyklické deriváty, způsob jejich přípravy, tyto deriváty pro použití jako léčiva, farmaceutická kompozice a kombinovaný farmaceutický přípravek tyto deriváty obsahující a použití těchto derivátů pro výrobu léčiv |
| GB9903762D0 (en) * | 1999-02-18 | 1999-04-14 | Novartis Ag | Organic compounds |
| US7125875B2 (en) | 1999-04-15 | 2006-10-24 | Bristol-Myers Squibb Company | Cyclic protein tyrosine kinase inhibitors |
| FR2793794B1 (fr) * | 1999-05-21 | 2001-07-27 | Hoechst Marion Roussel Inc | Nouveaux derives de la purine, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilisation |
| GB9918035D0 (en) * | 1999-07-30 | 1999-09-29 | Novartis Ag | Organic compounds |
| ATE322494T1 (de) * | 2000-01-07 | 2006-04-15 | Universitaire Instelling Antwe | Purin derivate, ihre herstellung und verwendung |
| WO2001082967A1 (fr) * | 2000-04-28 | 2001-11-08 | Yamanouchi Pharmaceutical Co., Ltd. | Compositions medicinales destinees a supprimer la production de ?-amyloide |
| US6861524B2 (en) | 2000-10-31 | 2005-03-01 | Aventis Pharmaceuticals Inc. | Acyl and sulfonyl derivatives of 6,9-disubstituted 2-(trans-1,4-diaminocyclohexyl)-purines and their use as antiproliferative agents |
| FR2818642B1 (fr) | 2000-12-26 | 2005-07-15 | Hoechst Marion Roussel Inc | Nouveaux derives de la purine, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilistion |
| PE20030008A1 (es) | 2001-06-19 | 2003-01-22 | Bristol Myers Squibb Co | Inhibidores duales de pde 7 y pde 4 |
| EP1399446B1 (en) | 2001-06-27 | 2005-08-03 | Cyclacel Limited | 2,6,9-substituted purine derivatives and their use in the treatment of proliferative disorders |
| CZ294535B6 (cs) * | 2001-08-02 | 2005-01-12 | Ústav Experimentální Botaniky Avčr | Heterocyklické sloučeniny na bázi N6-substituovaného adeninu, způsoby jejich přípravy, jejich použití pro přípravu léčiv, kosmetických přípravků a růstových regulátorů, farmaceutické přípravky, kosmetické přípravky a růstové regulátory tyto sloučeniny obsahující |
| CA2450777C (en) | 2001-08-10 | 2013-04-09 | Novartis Ag | Use of c-src inhibitors alone or in combination with sti571 for the treatment of leukaemia |
| EP1578722A4 (en) * | 2001-10-12 | 2006-09-06 | Irm Llc | KINASEINHIBITOR SCAFFOLD AND METHOD FOR THE PRODUCTION THEREOF |
| GB0219054D0 (en) | 2002-08-15 | 2002-09-25 | Cyclacel Ltd | New purine derivatives |
| GB0219052D0 (en) | 2002-08-15 | 2002-09-25 | Cyclacel Ltd | New puring derivatives |
| AR041292A1 (es) | 2002-09-19 | 2005-05-11 | Schering Corp | Pirazolopiridinas como inhibidores de quinasa dependientes de ciclina |
| WO2004035132A2 (en) * | 2002-10-15 | 2004-04-29 | Irm Llc | Compositions and methods for inducing osteogenesis |
| JP2006521398A (ja) * | 2003-03-28 | 2006-09-21 | サイオス・インコーポレーテツド | TGFβの二−環式ピリミジン阻害剤 |
| US7173031B2 (en) * | 2004-06-28 | 2007-02-06 | Bristol-Myers Squibb Company | Pyrrolotriazine kinase inhibitors |
| US7439246B2 (en) | 2004-06-28 | 2008-10-21 | Bristol-Myers Squibb Company | Fused heterocyclic kinase inhibitors |
| JP5400388B2 (ja) * | 2005-12-15 | 2014-01-29 | ライジェル ファーマシューティカルズ, インコーポレイテッド | キナーゼインヒビターおよびその利用 |
| BRPI0720264B1 (pt) * | 2006-12-08 | 2022-03-03 | Novartis Ag | Compostos e composições como inibidores de proteína cinase |
| EP2311807B1 (en) | 2006-12-08 | 2015-11-11 | Novartis AG | Compounds and composition as protein kinase inhibitors |
| EP2132208A1 (en) * | 2007-03-28 | 2009-12-16 | NeuroSearch AS | Purinyl derivatives and their use as potassium channel modulators |
| JP2010522719A (ja) * | 2007-03-28 | 2010-07-08 | ノイロサーチ アクティーゼルスカブ | プリニル誘導体及びカリウムチャネルモジュレーターとしてのそれらの使用 |
| CZ302225B6 (cs) * | 2007-07-04 | 2010-12-29 | Univerzita Palackého v Olomouci | Substituované 6-anilinopurinové deriváty jako inhibitory cytokinin oxidasy a prípravky obsahující tyto slouceniny |
| US8592432B2 (en) * | 2008-04-07 | 2013-11-26 | Bei Chen | Compounds and compositions as protein kinase inhibitors |
| EP2344501A1 (en) * | 2008-09-26 | 2011-07-20 | NeuroSearch A/S | Substituted purinyl-pyrazol derivatives and their use as potassium channel modulators |
| WO2010034707A1 (en) | 2008-09-26 | 2010-04-01 | Neurosearch A/S | Substituted purinyl-pyrazol derivatives and their use as potassium channel modulators |
| BR112013023050A8 (pt) | 2011-03-09 | 2018-09-25 | G Pestell Richard | antagonista de ccr5, método para determinar se um indivíduo humano tendo câncer de próstata está sofrendo de ou sob o risco de desenvolver metástase, para identificar um antagonista de ccr5, método para determinar se um indivíduo humano tendo câncer de próstata está sofrendo de ou sob o risco de desenvolver metástase, para identificar um composto candidato, para produzir in vitro células epiteliais primárias, para diagnosticar câncer de próstata, para selecionar um tratamento para um indivíduo tendo um câncer/tumor de próstata, linhagem de célula, e, modelo animal |
| CA2856291C (en) | 2011-11-17 | 2020-08-11 | Dana-Farber Cancer Institute, Inc. | Inhibitors of c-jun-n-terminal kinase (jnk) |
| AU2013262977A1 (en) | 2012-05-14 | 2015-01-22 | Prostagene, Llc | Using modulators of CCR5 for treating cancer |
| CA2876780A1 (en) | 2012-06-26 | 2014-01-03 | Saniona Aps | A phenyl triazole derivative and its use for modulating the gabaa receptor complex |
| CN105283206B (zh) * | 2013-03-27 | 2019-11-08 | 财团法人峨山社会福祉财团 | 包含p34的表达抑制剂或活性抑制剂作为有效成分的用于治疗或转移抑制癌的组合物 |
| US10047070B2 (en) | 2013-10-18 | 2018-08-14 | Dana-Farber Cancer Institute, Inc. | Polycyclic inhibitors of cyclin-dependent kinase 7 (CDK7) |
| US11920164B2 (en) | 2014-07-30 | 2024-03-05 | Yeda Research And Development Co. Ltd. | Media for culturing naive human pluripotent stem cells |
| AU2015371251B2 (en) | 2014-12-23 | 2020-06-11 | Dana-Farber Cancer Institute, Inc. | Inhibitors of cyclin-dependent kinase 7 (CDK7) |
| HK1246645A1 (zh) * | 2015-03-27 | 2018-09-14 | 达纳-法伯癌症研究所股份有限公司 | 细胞周期蛋白依赖性激酶的抑制剂 |
| EP3347018B1 (en) | 2015-09-09 | 2021-09-01 | Dana-Farber Cancer Institute, Inc. | Inhibitors of cyclin-dependent kinases |
| CN114149432B (zh) * | 2016-09-30 | 2024-07-05 | 斯坦福国际研究院 | 用于癌症治疗的双重clk/cdk1抑制剂 |
| US12187701B2 (en) | 2018-06-25 | 2025-01-07 | Dana-Farber Cancer Institute, Inc. | Taire family kinase inhibitors and uses thereof |
| WO2020152686A1 (en) | 2019-01-23 | 2020-07-30 | Yeda Research And Development Co. Ltd. | Culture media for pluripotent stem cells |
| CN120289460A (zh) * | 2024-01-09 | 2025-07-11 | 中国科学院合肥物质科学研究院 | 含有嘌呤环的化合物及其用途 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3529497A1 (de) | 1985-08-17 | 1987-02-26 | Boehringer Mannheim Gmbh | N(pfeil hoch)6(pfeil hoch)-disubstituierte purinderivate, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel |
| AU626983B2 (en) | 1989-01-31 | 1992-08-13 | Whitby Research, Inc. | N6-substituted 9-methyladenines |
| EP0625158B1 (en) * | 1992-01-06 | 1999-03-31 | The Wellcome Foundation Limited | Therapeutic nucleosides of the 2',3'-dideoxy-3'-fluoro-purine series |
| US6403599B1 (en) | 1995-11-08 | 2002-06-11 | Pfizer Inc | Corticotropin releasing factor antagonists |
| FR2741881B1 (fr) | 1995-12-01 | 1999-07-30 | Centre Nat Rech Scient | Nouveaux derives de purine possedant notamment des prorietes anti-proliferatives et leurs applications biologiques |
| US6107300A (en) | 1996-03-27 | 2000-08-22 | Dupont Pharmaceuticals | Arylamino fused pyrimidines |
| US5866702A (en) | 1996-08-02 | 1999-02-02 | Cv Therapeutics, Incorporation | Purine inhibitors of cyclin dependent kinase 2 |
| US5753635A (en) | 1996-08-16 | 1998-05-19 | Berlex Laboratories, Inc. | Purine derivatives and their use as anti-coagulants |
| AU4920397A (en) | 1996-10-11 | 1998-05-11 | Chiron Corporation | Purine inhibitors of glycogen synthase kinase 3 (gsk3) |
| GB9903762D0 (en) * | 1999-02-18 | 1999-04-14 | Novartis Ag | Organic compounds |
| EP1578722A4 (en) * | 2001-10-12 | 2006-09-06 | Irm Llc | KINASEINHIBITOR SCAFFOLD AND METHOD FOR THE PRODUCTION THEREOF |
| WO2004035132A2 (en) * | 2002-10-15 | 2004-04-29 | Irm Llc | Compositions and methods for inducing osteogenesis |
-
1996
- 1996-10-22 BR BR9611157A patent/BR9611157A/pt not_active Application Discontinuation
- 1996-10-22 JP JP50604797A patent/JP4004066B2/ja not_active Expired - Fee Related
- 1996-10-22 EP EP96934774A patent/EP0874846B1/en not_active Expired - Lifetime
- 1996-10-22 US US09/051,827 patent/US7091346B1/en not_active Expired - Fee Related
- 1996-10-22 CA CA002234609A patent/CA2234609C/en not_active Expired - Fee Related
- 1996-10-22 WO PCT/EP1996/004573 patent/WO1997016452A1/en not_active Ceased
- 1996-10-22 ES ES96934774T patent/ES2196181T3/es not_active Expired - Lifetime
- 1996-10-22 AU AU72968/96A patent/AU7296896A/en not_active Abandoned
- 1996-10-22 DE DE69627195T patent/DE69627195T2/de not_active Expired - Lifetime
- 1996-10-22 CN CN96198457.0A patent/CN1066147C/zh not_active Expired - Fee Related
- 1996-10-22 PT PT96934774T patent/PT874846E/pt unknown
- 1996-10-22 AT AT96934774T patent/ATE236161T1/de not_active IP Right Cessation
- 1996-10-30 AR ARP960104961A patent/AR004134A1/es unknown
-
2007
- 2007-06-05 JP JP2007148965A patent/JP2007231023A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO1997016452A1 (en) | 1997-05-09 |
| US7091346B1 (en) | 2006-08-15 |
| JP4004066B2 (ja) | 2007-11-07 |
| CN1066147C (zh) | 2001-05-23 |
| ES2196181T3 (es) | 2003-12-16 |
| AU7296896A (en) | 1997-05-22 |
| CA2234609A1 (en) | 1997-05-09 |
| CN1202896A (zh) | 1998-12-23 |
| DE69627195D1 (de) | 2003-05-08 |
| EP0874846A1 (en) | 1998-11-04 |
| JP2007231023A (ja) | 2007-09-13 |
| AR004134A1 (es) | 1998-09-30 |
| ATE236161T1 (de) | 2003-04-15 |
| EP0874846B1 (en) | 2003-04-02 |
| BR9611157A (pt) | 1999-03-30 |
| DE69627195T2 (de) | 2004-01-29 |
| JPH11514336A (ja) | 1999-12-07 |
| PT874846E (pt) | 2003-08-29 |
| HK1016580A1 (en) | 1999-11-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2234609C (en) | 2-amino-6-anilino-purine derivatives and processes for their preparation | |
| EP1153024B1 (en) | 2-amino-6-anilino-purines and their use as medicaments | |
| CN113004269B (zh) | Kras-G12C抑制剂杂环化合物 | |
| EP0938486B1 (en) | Substituted pyrrolopyrimidines and processes for their preparation | |
| AP160A (en) | Therapeutic acyclic nucleosides. | |
| TW434242B (en) | 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative | |
| CN112689638A (zh) | 作为lsd1抑制剂的环丙胺类化合物及其应用 | |
| US20040102462A1 (en) | 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1,3-propanediol derivative | |
| CA2535620A1 (en) | 6-substituted anilino purines as rtk inhibitors | |
| EP1789045A2 (en) | Chemical compounds | |
| US5543414A (en) | Achiral amino acid acyl esters of ganciclovir and its derivatives | |
| CZ292169B6 (cs) | Acyklické nukleosidové deriváty, způsob jejich přípravy a farmaceutické kompozice s jejich obsahem | |
| US20050250795A1 (en) | Synthesis of acyclic nucleoside derivatives | |
| EP0763041A1 (en) | Indolocarbazole derivatives for sensitizing multidrug-resistant cells to antitumor agents | |
| HK1016580B (en) | Purine derivatives and processes for their preparation | |
| WO1995032976A1 (en) | Polycyclic lactam derivatives for sensitizing multidrug-resistant cells to antitumour agents | |
| EP0971923A2 (en) | Synthesis of acyclic nucleoside derivatives | |
| HK1042479B (en) | 2-amino-6-anilino-purines and their use as medicaments | |
| MXPA99007340A (en) | Synthesis of acyclic nucleoside derivatives | |
| HK1012339B (en) | 2-(2-amino-1, 6-dihydro-6-oxo-purin-9-yl)methoxy-1, 3-propanediol derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |